
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">



<head id="Head1"><meta name="google-site-verification" content="_VGwTV0Z3wNC7pQw33rX86U_BGdiQMqGvEu9XPCrV54" />
                
    <!--MOBIFY - DO NOT ALTER - PASTE IMMEDIATELY AFTER OPENING HEAD TAG -->
    <style type="text/css">
        .bannerTopo {
            width: 100%;
            height: auto;
            float: left;

        }
        .colorbox_login {
        }
    </style>
    
    <script type="text/javascript">
        /*<![CDATA[*/
        (function (n, p) {
            function d(a) {
                if (a.mode) {
                    var b = c("mobify-mode");
                    b && a[b] || (b = a.mode(l.ua));
                    return a[b]
                }
                return a
            }

            function g() {
                function a(b) {
                    n.addEventListener(b, function () {
                        l[b] = +new Date
                    }, !1)
                }
                n.addEventListener && (a("DOMContentLoaded"), a("load"))
            }

            function h() {
                var a = new Date;
                a.setTime(a.getTime() + 300000);
                p.cookie = "mobify-path=; expires=" + a.toGMTString() + "; path=/";
                n.location.reload()
            }

            function k() {
                e({
                    src: "https://preview.mobify.com/v7/"
                })
            }

            function c(a) {
                if (a = p.cookie.match(RegExp("(^|; )" + a + "((=([^;]*))|(; |$))"))) {
                    return a[4] || ""
                }
            }

            function f(a) {
                p.write('<plaintext style="display:none">');
                setTimeout(function () {
                    m.capturing = !0;
                    a()
                }, 0)
            }

            function e(j, o) {
                var i = p.getElementsByTagName("script")[0],
                    a = p.createElement("script"),
                    b;
                for (b in j) {
                    a[b] = j[b]
                }
                o && a.setAttribute("class", o);
                i.parentNode.insertBefore(a, i)
            }
            var m = n.Mobify = {},
                l = m.Tag = {};
            m.points = [+new Date];
            m.tagVersion = [7, 0];
            l.ua = n.navigator.userAgent;
            l.getOptions = d;
            l.init = function (b) {
                l.options = b;
                if ("" !== c("mobify-path")) {
                    if (g(), b.skipPreview || "true" != c("mobify-path") && !/mobify-path=true/.test(n.location.hash)) {
                        var i = d(b);
                        if (i) {
                            var a = function () {
                                i.post && i.post()
                            };
                            b = function () {
                                i.pre && i.pre();
                                e({
                                    id: "mobify-js",
                                    src: i.url,
                                    onerror: h,
                                    onload: a
                                }, "mobify")
                            };
                            !1 === i.capture ? b() : f(b)
                        }
                    } else {
                        f(k)
                    }
                }
            }
        })(window, document);
        (function () {
            var b = "//cdn.mobify.com/sites/onofre-mobile/production/adaptive.min.js";
            Mobify.Tag.init({
                mode: function (a) {
                    return /^((?!windows\sphone).)*(ip(hone|od)|android.*(mobile)(?!.*firefox))/i.test(a) ? "enabled" : "desktop"
                },
                enabled: {
                    url: b
                },
                desktop: {
                    capture: !1,
                    url: "//a.mobify.com/onofre-mobile/a.js"
                }
            })
        })(); /*]]>*/
    </script>
    <!-- END MOBIFY -->
    <script language="javascript" type="text/javascript">window.chaordic_meta = { "page": { "name": "product", "timestamp": new Date(),"selected_specs": {"sales_channel": "24"},"categories": [{"name": "Medicamentos","id": "55"},{"name": "Antiparkinsoniano","id": "91","parents": ["55"]}]},"product": {"id": "32768","name": "Prolopa Dispersível 100/25mg 30 Comprimidos","url": "/prolopa-dispersivel-10025mg-30-comprimidos/32768/05","description": "Levedopa+Cloridrato de Benserazida","images": {"300x300": "https://www.onofre.com.br/img/Busca/imagem_prescricao.jpg"},"categories": [{"name": "Medicamentos","id": "55"},{"name": "Antiparkinsoniano","id": "91","parents": ["55"]}],"installment": {"count": 1,"price":50.77},"extra_info": {"otc": "yes"},"details": {"rating": {"total": "0","value": "0",},"codigo_interno": "124338","registro_ms": "1010000640126","volume": "0","quantidade": "30","generico": "nao","consulta_genericos": "False","programa_beneficio": "False","marca": "Roche Quimicos","urlMarca": "/busca/0/0/0/0/724/0/0/08"},"old_price": 65.93,"price": 50.77,"ean_code": "7896226503721","brand": "Roche Quimicos","status": "available","skus": [{"sku": "124338","specs": {"sales_channel": "20"},"price": 50.08,"old_price": 64.26,"installment": {"count": 1,"price":50.08},"status": "unavailable"},{"sku": "124338","specs": {"sales_channel": "8"},"price": 42.84,"old_price": 57.12,"installment": {"count": 1,"price":42.84},"status": "unavailable"},{"sku": "124338","specs": {"sales_channel": "27"},"price": 48.78,"old_price": 65.04,"installment": {"count": 1,"price":48.78},"status": "unavailable"},{"sku": "124338","specs": {"sales_channel": "34"},"price": 48.78,"old_price": 65.04,"installment": {"count": 1,"price":48.78},"status": "unavailable"},{"sku": "124338","specs": {"sales_channel": "38"},"price": 48.78,"old_price": 65.04,"installment": {"count": 1,"price":48.78},"status": "unavailable"},{"sku": "124338","specs": {"sales_channel": "737"},"price": 50.08,"old_price": 65.04,"installment": {"count": 1,"price":50.08},"status": "unavailable"},{"sku": "124338","specs": {"sales_channel": "750"},"price": 50.08,"old_price": 65.04,"installment": {"count": 1,"price":50.08},"status": "unavailable"},{"sku": "124338","specs": {"sales_channel": "783"},"price": 50.08,"old_price": 64.26,"installment": {"count": 1,"price":50.08},"status": "unavailable"},{"sku": "124338","specs": {"sales_channel": "12"},"price": 50.77,"old_price": 65.93,"installment": {"count": 1,"price":50.77},"status": "available"},{"sku": "124338","specs": {"sales_channel": "18"},"price": 50.77,"old_price": 67.57,"installment": {"count": 1,"price":50.77},"status": "available"},{"sku": "124338","specs": {"sales_channel": "24"},"price": 50.77,"old_price": 65.93,"installment": {"count": 1,"price":50.77},"status": "available"},{"sku": "124338","specs": {"sales_channel": "144"},"price": 50.77,"old_price": 65.93,"installment": {"count": 1,"price":50.77},"status": "available"}],"specs": {"sales_channel": ["20","8","27","34","38","737","750","783","12","18","24","144"]}}}</script>
    <!--Script Chaordic Loader-->
    <script async defer src="//static.chaordicsystems.com/static/loader.js" data-apikey="onofrefarma"></script>
    <!--<script type="text/javascript"> var headID = document.getElementsByTagName("head")[0]; var newScript = document.createElement('script'); newScript.type = 'text/javascript'; newScript.src = '//static.chaordicsystems.com/static/loader.js'; newScript.setAttribute('data-apikey', 'onofrefarma'); newScript.async = true; newScript.defer = true; headID.appendChild(newScript); </script> -->
    <!--Script Chaordic Loader - FIM -->
    <meta name="viewport" content="width=device-width, initial-scale=1.0" /><meta http-equiv="X-UA-Compatible" content="IE=8" /><title>
	Prolopa Dispersível 100/25mg 30 Comprimidos | Onofre 
</title>

    <script src="Jss/gaEventos.js"></script>
    <link type="image/x-icon" href="https://www.onofre.com.br/favicon.ico" rel="icon" /><link type="image/x-icon" href="https://www.onofre.com.br/favicon.ico" rel="SHORTCUT ICON" />
        <!-- CSS -->
        <link href="/Jss/Colorbox/colorbox.css" rel="stylesheet"/>
<link href="/Jss/ToolTip/bubbletip/bubbletip.css" rel="stylesheet"/>
<link href="/Jss/ToolTip/bubbletip/bubbletip-IE.css" rel="stylesheet"/>
<link href="/Css/resetNovo.css" rel="stylesheet"/>
<link href="/Css/star_rating.css" rel="stylesheet"/>
<link href="/Css/EstiloMasterNovo.css" rel="stylesheet"/>
<link href="/Css/MasterNova.css" rel="stylesheet"/>
<link href="/shadowbox/shadowbox.css" rel="stylesheet"/>
<link href="/Css/rodape.css" rel="stylesheet"/>
<link href="/Css/EstiloExtraBucks.css" rel="stylesheet"/>
<link href="/assets/css/base.css" rel="stylesheet"/>
<link href="/assets/css/common.css" rel="stylesheet"/>

        <link href="/Css/AutenticacaoPBM.css" rel="stylesheet" />
        <!-- CSS -->
        <!-- JSS -->
        <script src="/Jss/jquery_onofre.js"></script>
<script src="/Jss/jquery.maskMoney.js"></script>
<script src="/shadowbox/shadowbox.js"></script>
<script src="/Jss/jquery.cookie.js"></script>
<script src="/Jss/Colorbox/jquery.colorbox-min.js"></script>
<script src="/Jss/Dialog/jquery-ui-1.10.1.custom.min.js"></script>
<script src="/Jss/generic.js"></script>
<script src="/Jss/jqzoom.pack.1.0.1.js"></script>
<script src="/Jss/jquery.hoverIntent.minified.js"></script>
<script src="/Jss/ToolTip/jQuery.bubbletip-1.0.6.js"></script>
<script src="/Jss/ToolTip/ToolTip.js"></script>
<script src="/assets/js/lib/owl.carousel.min.js"></script>
<script src="/assets/js/main.js"></script>
<script src="/Jss/Utils/MasterPage.js"></script>

        <script src="/Jss/AutenticaFloatBar.js"></script>
        <link href="/Css/select2.min.css" rel="stylesheet" />
        <script src="/Jss/Utils/select2.min.js"></script>
        <link href="/Css/MasterResponsivo.css" rel="stylesheet" />
        <script src="/Jss/Utils/Home.js"></script>
        <script type="text/javascript" src='https://www.google.com/recaptcha/api.js'></script>
        <!-- JSS -->
    
    <!--[if lt IE 9]> <script src="https://html5shim.googlecode.com/svn/trunk/html5.js"></script> <![endif]-->
    <!-- JSS -->
    
    
    
    <script type='text/javascript' src='https://v2.afilio.com.br/mastertag.php?progid=1719&type=product&id_partner=drogariaonofre&product_id1=32768&id_category=0&stock=0&product_sku=&product_name=PROLOPA DISP 100/25MG 30S&product_desc=Prolopa Dispersível 100/25mg 30 Comprimidos&product_photo=https://www.onofre.com.br/estatico/Produto/Normal/&price1=50,77&price2=65,93&product_currency=BRL&url_product=http://www.onofre.com.br/DetalheProduto/Default.aspx?ProductName=prolopa-dispersivel-10025mg-30-comprimidos&ProductId=32768'></script>
    <link href="/Css/EstiloDetalheProduto.css" rel="stylesheet"/>
<link href="/Css/jqzoom.css" rel="stylesheet"/>
<link href="/Jss/Colorbox/colorbox.css" rel="stylesheet"/>
<link href="/assets/css/prateleira.css" rel="stylesheet"/>
<link href="/assets/css/produto.css" rel="stylesheet"/>
<script type="text/javascript" src="/Jss/DetalheProduto.js" defer></script>
<script type="text/javascript" src="/Jss/jqzoom.pack.1.0.1.js" defer></script>
<script type="text/javascript" src="/Jss/zoom/jquery.jqzoom-core.js" defer></script>
<script type="text/javascript" src="/jss/zoom/zoom.js" defer></script>
<script type="text/javascript" src="/Jss/Colorbox/jquery.colorbox-min.js" defer></script>
<script type="text/javascript" src="/Jss/Utils/DetalheProduto.js" defer></script>
<script type="text/javascript" src="/assets/js/produto.js" defer></script>

    <script type="text/javascript">        /*<![CDATA[*/ var dataLayer = [{
                               'site' : { 'domain' : document.location.host },
                               'page' : { 
                                            'name' : document.title,
                                            'pageType' : 'product'
                                        },
                                               'product' : {
                                               'productName' : 'PROLOPA DISP 100/25MG 30 S',
                                               'productId' : '32768',
                                               'productCategory' : '',
                                               'productSubCategory' : '',
                                               'productPrice' : '50.77',
                                               'productBrand' : 'Roche Quimicos'
                                           },
                               'session' : {
                                                'isLogged': false,
                                                'user' : { 'id' : 'VISIT-735072931' }
                                           }
                                }];; /*]]>*/ </script>
<link rel="stylesheet" type="text/css" href="//onofre.resultspage.com/autocomplete/sli-rac.css" /><meta name="description" content="Prolopa Dispersível 100/25mg 30 Comprimidos da Roche Quimicos com o menor preço é na Onofre. Receba seu pedido em casa pagando em até 3x. Compre agora!" /></head>
            

<body id="body" class="produto">

    <!-- BANNER TOPO -->
    
    <div class="bannerTopo" style="max-height: 100px">
        
    </div>
    <!-- FIM - BANNER TOPO -->
    <script type="text/javascript" src="//onofre.resultspage.com/autocomplete/sli-rac.config.js"></script>
    
    <!-- Start Alexa Certify Javascript -->
    <script type="text/javascript" src="https://d31qbv1cthcecs.cloudfront.net/atrk.js"></script>
    <script type="text/javascript">
        _atrk_opts = {
            atrk_acct: "xfCse1aALO00g7",
            domain: "onofre.com.br"
        };
        atrk();
    </script>
    <noscript>
        <img src="https://d5nxst8fruw4z.cloudfront.net/atrk.gif?account=xfCse1aALO00g7" style="display: none" height="1" width="1" alt="" />
    </noscript>
    <script type="text/javascript">
        /* Set the width of the side navigation to 250px */
        function openNavMobile() {
            document.getElementById("mySidenav").style.width = "255px";
        } /* Set the width of the side navigation to 0 */
        function closeNavMobile() {
            document.getElementById("mySidenav").style.width = "0";
        }
    </script>
    <!-- End Alexa Certify Javascript -->
    <form method="post" action="/prolopa-dispersivel-10025mg-30-comprimidos/32768/05" id="form1">
<input type="hidden" name="__VIEWSTATE" id="__VIEWSTATE" value="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" />

<script> ECO_Step='Product';</script><script> ECO_DepName='';</script><script> ECO_DepId='';</script><script> ECO_CatName='';</script><script> ECO_CatId='';</script><script> ECO_ProdName='prolopa-dispersivel-10025mg-30-comprimidos';</script><script> ECO_ProdId='32768';</script><script> ECO_ProdValue='50.77';</script><script> ECO_ProdSumValue='50.77';</script><script> ECO_ProdQty='1';</script><script> ECO_ProdAvgValue='50,77';</script>
<script type="text/javascript">
//<![CDATA[
products = []; products.push( {'id':124338,'name':'Prolopa Dispersível 100/25mg 30 Comprimidos','category':'Antiparkinsoniano','price':50.77,'quantity':0,'brandId':724});var productData ={   'transaction': {'id':0,     'products': products}};//]]>
</script>

<script src="/ScriptResource.axd?d=BnWrJ6-gLV3GlI8g28LCzYXkfKJLttyoigz0AJpfnvO4NN21YTBbDD9JctBIuGGW8YufhqFw-AnVHbmyWvfFb_B2w9DMLRk3OO9iqYmkxfGcvnVf4ImxaGFLKlWYiwlxPddzmc-9JHkJ8clChxff5mADpJw1&amp;t=42a7acab" type="text/javascript"></script>
<input type="hidden" name="__VIEWSTATEGENERATOR" id="__VIEWSTATEGENERATOR" value="53BE6E71" />
<input type="hidden" name="__EVENTVALIDATION" id="__EVENTVALIDATION" value="/wEdAAuaLK0ieQ2Uv+0yTqatkYdlvGJREAXUqdHbn/uqryQegasCjseFQU1IG6a1QV/1IsPDvqD576IjU8b+VycT56M9ED22EwkGKj1YkpT+X+kXiM56f9BvruTcOsm75dsnP4j+rR3kChNt2jv+P1A6lf1Kfh0m/YFL+gqaOapTOLGCT3uEmapvkS7PnXX2p48aV5JXiYT1tmrUuDA14lwoxMmxwwFaVvdlxqKyIPzmKQOht7iNohc0XznIHJwQveSPil6gQtKv" />
        
        <!-- Master -->
        
        <!-- Header -->
        <div id="mySidenav" class="sidenav">
            
            <a href="javascript:void(0)" id="divMobileLogin"><span style="float: left; font-size: 18px; text-decoration: underline" onclick="window.location.href='https://www.onofre.com.br/acesso/'">Faça o login ou cadastre-se</span>
                <br />
                <span class="closebtn" onclick="closeNavMobile()">&times;</span></a>
            <!--<a href="#">About</a> <a href="#">Services</a> <a href="#">Clients</a> <a href="#">Contact</a>-->
            <hr />
            <nav id="mobile-nav" class="page-nav">
                                    <div class="wrapper full">
                                        <ul class="nav-list">
                                            <li class="medicamentos-e-saude"><a onclick="$('.medicamentos-e-saude .sub-nav').toggle();" title="Medicamentos" class="nav-link">Medicamentos</a>
                                                <div class="sub-nav">
                                                    <ul class='medi-sub-nav-col'><li class='medi-sub-nav-item-titulo'><p>Intestino e Digestão</p></li><li class='medi-sub-nav-item'><a href='/medicamentos/saude-digestiva/44/03' class='medi-sub-nav-link' >Saúde Digestiva</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/antiflatulento/54/03' class='medi-sub-nav-link' >Antiflatulento</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/antiacido/95/03' class='medi-sub-nav-link' >Antiácido</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/laxante/248/03' class='medi-sub-nav-link' >Laxante</a></li><li class='medi-sub-nav-item'><a href='/medicamento/55/01' class='medi-sub-nav-link-vejamais' >(+) Veja Mais</a></li></ul><ul class='medi-sub-nav-col'><li class='medi-sub-nav-item-titulo'><p>Diabetes</p></li><li class='medi-sub-nav-item'><a href='/medicamentos/hipoglicemiante/234/03' class='medi-sub-nav-link' >Hipoglicemiante</a></li><li class='medi-sub-nav-item'><a href='/medicamento/55/01' class='medi-sub-nav-link-vejamais' >(+) Veja Mais</a></li></ul><ul class='medi-sub-nav-col'><li class='medi-sub-nav-item-titulo'><p>Hormônios</p></li><li class='medi-sub-nav-item'><a href='/medicamentos/antigotoso/57/03' class='medi-sub-nav-link' >Antigotoso</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/tireoidiano/342/03' class='medi-sub-nav-link' >Tireoidiano</a></li><li class='medi-sub-nav-item'><a href='/medicamento/55/01' class='medi-sub-nav-link-vejamais' >(+) Veja Mais</a></li></ul><ul class='medi-sub-nav-col'><li class='medi-sub-nav-item-titulo'><p>Infecções</p></li><li class='medi-sub-nav-item'><a href='/medicamentos/antibiotico/32/03' class='medi-sub-nav-link' >Antibiótico</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/anti-infeccioso/67/03' class='medi-sub-nav-link' >Anti-infeccioso</a></li><li class='medi-sub-nav-item'><a href='/medicamento/55/01' class='medi-sub-nav-link-vejamais' >(+) Veja Mais</a></li></ul><ul class='medi-sub-nav-col'><li class='medi-sub-nav-item-titulo'><p>Aparelho Urinário</p></li><li class='medi-sub-nav-item'><a href='/medicamentos/antidiuretico/46/03' class='medi-sub-nav-link' >Antidiurético</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/antilitiasico/80/03' class='medi-sub-nav-link' >Antilitiásico</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/diuretico/190/03' class='medi-sub-nav-link' >Diurético</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/incontinencia-urinaria/242/03' class='medi-sub-nav-link' >Incontinência Urinária</a></li><li class='medi-sub-nav-item'><a href='/medicamento/55/01' class='medi-sub-nav-link-vejamais' >(+) Veja Mais</a></li></ul><ul class='medi-sub-nav-col'><li class='medi-sub-nav-item-titulo'><p>Sistema Nervoso</p></li><li class='medi-sub-nav-item'><a href='/medicamentos/antivertiginoso/112/03' class='medi-sub-nav-link' >Antivertiginoso</a></li><li class='medi-sub-nav-item'><a href='/homeopaticos/calmante/147/03' class='medi-sub-nav-link' >Calmante</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/disturbio-do-tubo-neural/188/03' class='medi-sub-nav-link' >Distúrbio do Tubo Neural</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/neuropsicoestimulante/278/03' class='medi-sub-nav-link' >Neuropsicoestimulante</a></li><li class='medi-sub-nav-item'><a href='/medicamento/55/01' class='medi-sub-nav-link-vejamais' >(+) Veja Mais</a></li></ul><ul class='medi-sub-nav-col'><li class='medi-sub-nav-item-titulo'><p>Gripe e Resfriado</p></li><li class='medi-sub-nav-item'><a href='/medicamentos/antitussigenos/109/03' class='medi-sub-nav-link' >Antitussígenos</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/descongestionante/179/03' class='medi-sub-nav-link' >Descongestionante</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/irritacoes-da-garganta/246/03' class='medi-sub-nav-link' >Irritações da Garganta</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/expectorante-e-mucolitico/274/03' class='medi-sub-nav-link' >Expectorante e Mucolítico</a></li><li class='medi-sub-nav-item'><a href='/medicamento/55/01' class='medi-sub-nav-link-vejamais' >(+) Veja Mais</a></li></ul><ul class='medi-sub-nav-col'><li class='medi-sub-nav-item-titulo'><p>Anti-Hipertensivo</p></li><li class='medi-sub-nav-item'><a href='/medicamentos/antiarritmico/27/03' class='medi-sub-nav-link' >Antiarritmico</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/anti-hipertensivo/62/03' class='medi-sub-nav-link' >Anti-hipertensivo</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/cardiotonico/149/03' class='medi-sub-nav-link' >Cardiotônico</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/hipertensor/231/03' class='medi-sub-nav-link' >Hipertensor</a></li><li class='medi-sub-nav-item'><a href='/medicamento/55/01' class='medi-sub-nav-link-vejamais' >(+) Veja Mais</a></li></ul><ul class='medi-sub-nav-col'><li class='medi-sub-nav-item-titulo'><p>Cuidado com os Olhos</p></li><li class='medi-sub-nav-item'><a href='/medicamentos/orgaos-sensoriais/56/03' class='medi-sub-nav-link' >Órgãos Sensoriais</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/descongestionante-ocular/180/03' class='medi-sub-nav-link' >Descongestionante Ocular</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/distrofia-do-globo-ocular/189/03' class='medi-sub-nav-link' >Distrofia do Globo Ocular</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/lubrificante-ocular/260/03' class='medi-sub-nav-link' >Lubrificante Ocular</a></li><li class='medi-sub-nav-item'><a href='/medicamento/55/01' class='medi-sub-nav-link-vejamais' >(+) Veja Mais</a></li></ul><ul class='medi-sub-nav-col'><li class='medi-sub-nav-item-titulo'><p>Sistema Circulatório</p></li><li class='medi-sub-nav-item'><a href='/medicamentos/antianemico/26/03' class='medi-sub-nav-link' >Antianêmico</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/anti-hemorragico/61/03' class='medi-sub-nav-link' >Anti-hemorrágico</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/antivaricoso/111/03' class='medi-sub-nav-link' >Antivaricoso</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/hemostatico/221/03' class='medi-sub-nav-link' >Hemostático</a></li><li class='medi-sub-nav-item'><a href='/medicamento/55/01' class='medi-sub-nav-link-vejamais' >(+) Veja Mais</a></li></ul><ul class='medi-sub-nav-col'><li class='medi-sub-nav-item-titulo'><p>Vermes e Parasitas</p></li><li class='medi-sub-nav-item'><a href='/medicamentos/antifungico/52/03' class='medi-sub-nav-link' >Antifúngico</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/antimalarico/81/03' class='medi-sub-nav-link' >Antimalárico</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/antiparasitario/90/03' class='medi-sub-nav-link' >Antiparasitário</a></li><li class='medi-sub-nav-item'><a href='/medicamento/55/01' class='medi-sub-nav-link-vejamais' >(+) Veja Mais</a></li></ul><ul class='medi-sub-nav-col'><li class='medi-sub-nav-item-titulo'><p>Dor e Febre</p></li><li class='medi-sub-nav-item'><a href='/medicamentos/analgesico/8/03' class='medi-sub-nav-link' >Analgésico</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/anestesico/13/03' class='medi-sub-nav-link' >Anestésico</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/antienxaquecoso/48/03' class='medi-sub-nav-link' >Antienxaquecoso</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/anti-inflamatorio/69/03' class='medi-sub-nav-link' >Anti-inflamatório</a></li><li class='medi-sub-nav-item'><a href='/medicamento/55/01' class='medi-sub-nav-link-vejamais' >(+) Veja Mais</a></li></ul><ul class='medi-sub-nav-col'><li class='medi-sub-nav-item-titulo'><p>Alergias</p></li><li class='medi-sub-nav-item'><a href='/medicamentos/antialergico/21/03' class='medi-sub-nav-link' >Antialérgico</a></li><li class='medi-sub-nav-item'><a href='/medicamento/55/01' class='medi-sub-nav-link-vejamais' >(+) Veja Mais</a></li></ul><ul class='medi-sub-nav-col'><li class='medi-sub-nav-item-titulo'><p>Sistema Respiratório</p></li><li class='medi-sub-nav-item'><a href='/medicamentos/antiasmatico/29/03' class='medi-sub-nav-link' >Antiasmático</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/broncodilatador/142/03' class='medi-sub-nav-link' >Broncodilatador</a></li><li class='medi-sub-nav-item'><a href='/medicamento/55/01' class='medi-sub-nav-link-vejamais' >(+) Veja Mais</a></li></ul><ul class='medi-sub-nav-col'><li class='medi-sub-nav-item-titulo'><p>Pele e Mucosa</p></li><li class='medi-sub-nav-item'><a href='/medicamentos/cicatrizante/155/03' class='medi-sub-nav-link' >Cicatrizante</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/despigmentante/182/03' class='medi-sub-nav-link' >Despigmentante</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/aftas/215/03' class='medi-sub-nav-link' >Aftas</a></li><li class='medi-sub-nav-item'><a href='/tratamento-rosto/antiacne/399/03' class='medi-sub-nav-link' >Antiacne</a></li><li class='medi-sub-nav-item'><a href='/medicamento/55/01' class='medi-sub-nav-link-vejamais' >(+) Veja Mais</a></li></ul><ul class='medi-sub-nav-col'><li class='medi-sub-nav-item-titulo'><p>Vitaminas e Suplementos</p></li><li class='medi-sub-nav-item'><a href='/medicamentos/antifadiga/53/03' class='medi-sub-nav-link' >Antifadiga</a></li><li class='medi-sub-nav-item'><a href='/nutricosmeticos/antioxidante/88/03' class='medi-sub-nav-link' >Antioxidante</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/orexigeno/281/03' class='medi-sub-nav-link' >Orexígeno</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/vitaminico/367/03' class='medi-sub-nav-link' >Vitamínico</a></li><li class='medi-sub-nav-item'><a href='/medicamento/55/01' class='medi-sub-nav-link-vejamais' >(+) Veja Mais</a></li></ul><ul class='medi-sub-nav-col'><li class='medi-sub-nav-item-titulo'><p>Saúde Masculina</p></li><li class='medi-sub-nav-item'><a href='/medicamentos/antialopecia/20/03' class='medi-sub-nav-link' >Antialopécia</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/antiandrogenico/24/03' class='medi-sub-nav-link' >Antiandrogénico</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/disfuncao-eretil/185/03' class='medi-sub-nav-link' >Disfunção Erétil</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/hiperplasia-prostatica-benigna/230/03' class='medi-sub-nav-link' >Hiperplasia Prostática Benigna</a></li><li class='medi-sub-nav-item'><a href='/medicamento/55/01' class='medi-sub-nav-link-vejamais' >(+) Veja Mais</a></li></ul><ul class='medi-sub-nav-col'><li class='medi-sub-nav-item-titulo'><p>Saúde Feminina</p></li><li class='medi-sub-nav-item'><a href='/medicamentos/anticoncepcionais/39/03' class='medi-sub-nav-link' >Anticoncepcionais</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/disturbio-do-ciclo-menstrual/187/03' class='medi-sub-nav-link' >Distúrbio do Ciclo Menstrual</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/indutor-da-ovulacao/243/03' class='medi-sub-nav-link' >Indutor da Ovulação</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/terapeutica-da-menopausa/337/03' class='medi-sub-nav-link' >Terapêutica da Menopausa</a></li><li class='medi-sub-nav-item'><a href='/medicamento/55/01' class='medi-sub-nav-link-vejamais' >(+) Veja Mais</a></li></ul><ul class='medi-sub-nav-col'><li class='medi-sub-nav-item-titulo'><p>Sistema Ósseo</p></li><li class='medi-sub-nav-item'><a href='/medicamentos/antiartrosico/28/03' class='medi-sub-nav-link' >Antiartrósico</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/antiosteoporotico/87/03' class='medi-sub-nav-link' >Antiosteoporótico</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/osteoporose/94/03' class='medi-sub-nav-link' >Osteoporose</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/repositor-de-potassio/315/03' class='medi-sub-nav-link' >Repositor de Potássio</a></li><li class='medi-sub-nav-item'><a href='/medicamento/55/01' class='medi-sub-nav-link-vejamais' >(+) Veja Mais</a></li></ul><ul class='medi-sub-nav-col'><li class='medi-sub-nav-item-titulo'><p>Controle Especial</p></li><li class='medi-sub-nav-item'><a href='/medicamentos/antidepressivo/42/03' class='medi-sub-nav-link' >Antidepressivo</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/antiparkinsoniano/91/03' class='medi-sub-nav-link' >Antiparkinsoniano</a></li><li class='medi-sub-nav-item'><a href='/medicamento/55/01' class='medi-sub-nav-link-vejamais' >(+) Veja Mais</a></li></ul><ul class='medi-sub-nav-col'><li class='medi-sub-nav-item-titulo'><p>Outros</p></li><li class='medi-sub-nav-item'><a href='/medicamentos/antineoplasico/84/03' class='medi-sub-nav-link' >Antineoplásico</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/antitabagismo/103/03' class='medi-sub-nav-link' >Antitabagismo</a></li><li class='medi-sub-nav-item'><a href='/medicamento/55/01' class='medi-sub-nav-link-vejamais' >(+) Veja Mais</a></li></ul>
                                                         </div>
                                            </li>
                                            <li class="medicamentos-e-saude_new"><a onclick="$('.medicamentos-e-saude_new .sub-nav').toggle();" title="Saúde" class="nav-link">Saúde</a>
                                                <div class="sub-nav">
                                                    <ul class="sub-nav-col">
                                                        <li class='sub-nav-item'><a href='/geriatria/46/01' class='sub-nav-link' title='Geriatria'>Geriatria</a></li><li class='sub-nav-item'><a href='/higiene-e-limpeza/48/01' class='sub-nav-link' title='Higiene e Limpeza'>Higiene e Limpeza</a></li><li class='sub-nav-item'><a href='/homeopaticos/50/01' class='sub-nav-link' title='Homeopáticos'>Homeopáticos</a></li><li class='sub-nav-item'><a href='/alimentos-e-bebidas/52/01' class='sub-nav-link' title='Alimentos e Bebidas'>Alimentos e Bebidas</a></li><li class='sub-nav-item'><a href='/medicamentos/55/01' class='sub-nav-link' title='Medicamentos'>Medicamentos</a></li><li class='sub-nav-item'><a href='/cuidado-com-os-olhos/57/01' class='sub-nav-link' title='Cuidado com os Olhos'>Cuidado com os Olhos</a></li><li class='sub-nav-item'><a href='/ortopedia-e-acessorios/58/01' class='sub-nav-link' title='Ortopedia e Acessórios'>Ortopedia e Acessórios</a></li><li class='sub-nav-item'><a href='/primeiros-socorros/60/01' class='sub-nav-link' title='Primeiros Socorros'>Primeiros Socorros</a></li><li class='sub-nav-item'><a href='/sexo-seguro/61/01' class='sub-nav-link' title='Sexo Seguro'>Sexo Seguro</a></li><li class='sub-nav-item'><a href='/fitness-e-dietas/62/01' class='sub-nav-link' title='Fitness e Dietas'>Fitness e Dietas</a></li><li class='sub-nav-item'><a href='/testes-e-aparelhos/63/01' class='sub-nav-link' title='Testes e Aparelhos'>Testes e Aparelhos</a></li><li class='sub-nav-item'><a href='/vitaminas-e-naturais/65/01' class='sub-nav-link' title='Vitaminas e Naturais'>Vitaminas e Naturais</a></li>
                                                    </ul>
                                                    <div class="banner-menu">
                                                        <a id="A2"> <img id="Img2" /></a>
                                                        > </div>
                                                </div>
                                            </li>
                                            <li class="beleza-e-bem-estar"><a onclick="$('.beleza-e-bem-estar .sub-nav').toggle();" title="Beleza e Bem Estar" class="nav-link">Beleza e Bem Estar</a>
                                                <div class="sub-nav">
                                                    <ul class="sub-nav-col">
                                                        <li class='sub-nav-item'><a href='/tratamento-rosto/39/01' class='sub-nav-link' title='Tratamento Rosto'>Tratamento Rosto</a></li><li class='sub-nav-item'><a href='/cabelos/40/01' class='sub-nav-link' title='Cabelos'>Cabelos</a></li><li class='sub-nav-item'><a href='/corpo-e-banho/42/01' class='sub-nav-link' title='Corpo e Banho'>Corpo e Banho</a></li><li class='sub-nav-item'><a href='/cuidados-femininos/44/01' class='sub-nav-link' title='Cuidados Femininos'>Cuidados Femininos</a></li><li class='sub-nav-item'><a href='/cuidados-masculinos/49/01' class='sub-nav-link' title='Cuidados Masculinos'>Cuidados Masculinos</a></li><li class='sub-nav-item'><a href='/maos-e-pes/53/01' class='sub-nav-link' title='Mãos e Pés'>Mãos e Pés</a></li><li class='sub-nav-item'><a href='/maquiagem/54/01' class='sub-nav-link' title='Maquiagem'>Maquiagem</a></li><li class='sub-nav-item'><a href='/nutricosmeticos/56/01' class='sub-nav-link' title='Nutricosméticos'>Nutricosméticos</a></li><li class='sub-nav-item'><a href='/colonias/59/01' class='sub-nav-link' title='Colônias'>Colônias</a></li><li class='sub-nav-item'><a href='/tratamento-do-corpo/64/01' class='sub-nav-link' title='Tratamento do Corpo'>Tratamento do Corpo</a></li><li class='sub-nav-item'><a href='/higiene-bucal/68/01' class='sub-nav-link' title='Higiene Bucal'>Higiene Bucal</a></li><li class='sub-nav-item'><a href='/protecao-solar/69/01' class='sub-nav-link' title='Proteção Solar'>Proteção Solar</a></li>
                                                    </ul>
                                                    <div class="banner-menu">
                                                        <a id="A3"> <img id="Img3" /></a>
                                                         </div>
                                                </div>
                                            </li>
                                            <li class="mamae-e-bebe"><a onclick="$('.mamae-e-bebe .sub-nav').toggle();" title="Mamãe e Bebê" class="nav-link">Mamãe e Bebê</a>
                                                <div class="sub-nav">
                                                    <ul class="sub-nav-col">
                                                        <li class='sub-nav-item'><a href='/acessorios-infantis/37/01' class='sub-nav-link' title='Acessórios Infantis'>Acessórios Infantis</a></li><li class='sub-nav-item'><a href='/alimentos-infantis/38/01' class='sub-nav-link' title='Alimentos Infantis'>Alimentos Infantis</a></li><li class='sub-nav-item'><a href='/corpo-e-banho-infantil/41/01' class='sub-nav-link' title='Corpo e Banho Infantil'>Corpo e Banho Infantil</a></li><li class='sub-nav-item'><a href='/cuidados-com-a-mamae/43/01' class='sub-nav-link' title='Cuidados com a Mamãe'>Cuidados com a Mamãe</a></li><li class='sub-nav-item'><a href='/troca-de-fraldas/45/01' class='sub-nav-link' title='Troca de Fraldas'>Troca de Fraldas</a></li><li class='sub-nav-item'><a href='/cuidado-bucal-infantil/47/01' class='sub-nav-link' title='Cuidado Bucal Infantil'>Cuidado Bucal Infantil</a></li>
                                                    </ul>
                                                    <div class="banner-menu">
                                                        <a id="A4"> <img id="Img4" /></a>
                                                         </div>
                                                </div>
                                            </li>
                                            <li class="ofertas-e-lancamentos"><a onclick="$('.ofertas-e-lancamentos .sub-nav').toggle();" title="Ofertas e Lançamentos" class="nav-link"> Ofertas e Lançamentos</a>
                                                <div class="sub-nav">
                                                    <ul class="sub-nav-col">
                                                        <li class="sub-nav-item"><a href="/Produtos/OfertasLancamentos/oferta/66" class="sub-nav-link" title="Ofertas">Ofertas</a></li>
                                                    </ul>
                                                    <ul class="sub-nav-col">
                                                        <li class="sub-nav-item"><a href="/Produtos/OfertasLancamentos/lancamento/66" class="sub-nav-link" title="Lançamentos">Lançamentos</a></li>
                                                    </ul>
                                                    <div class="banner-menu">
                                                        <a id="A5"> <img id="Img5" /></a>
                                                         </div>
                                                </div>
                                            </li>
                                            <li class="como-comprar"><a href="https://www.onofre.com.br/Institucional/Default.aspx?InstId=251" title="Como Comprar" class="nav-link">Como Comprar</a> </li>
                                        </ul>
                                    </div>
                                </nav>
        </div>
        <header id="main-header" class="page-header">
                                <!--<div class="topbar-responsive"> <div class="wrapper-responsive full"> <div class="televendas col"> <p><span>Televendas:</span> <strong>4007-2526</strong></p> </div> <div class="social-responsive"> <ul class="social-list"> <li class="social-item"><a href="https://www.facebook.com/DrogariaOnofreOficial" class="social-link facebook" target="_blank" title="Facebook">Facebook</a></li> <li class="social-item"><a href="https://blogonofre.wordpress.com/" class="social-link beonofre" target="_blank" title="BeOnofre">BeOnofre</a></li>  </ul> </div> </div> </div>-->
                                <div class="topbar">
                                    <div class="wrapper full">
                                        <div class="welcome col" style="width: 570px; margin-top: 20px;">
                                            <!-- usuario logado-->
                                            
                                            <!-- fim usuario logado-->

                                            <!-- usuario não logado-->
                                            <div id="divTopoLogin" class="login col">
                                                <div id="Panel2" class="login-form">
	
                                                    <div style="display: none">
                                                        <label for="identificacao">Faça seu login:</label>
                                                        <input name="ctl00$TxtUsuario" type="text" id="TxtUsuario" class="campo_texto" autocomplete="off" placeholder="Digite seu email ou cpf" />
                                                    </div>
                                                    <div id="divPasswordDoLogin" style="display: none">
                                                        <label for="senha">Senha</label>
                                                        <input name="ctl00$TxtSenha" type="password" id="TxtSenha" class="campo_texto" />
                                                    </div>
                                                    
                                                    <a class="welcome-msg" style="font-size: 12px; vertical-align: middle; font-family: Tahoma"> OLÁ VISITANTE, </a> 
                                                    <a class="action-link criar-conta" style="font-size: 12px; font-family: Tahoma" id="btnBoxLogin" onclick="ExibirPopupLogin('../../../../../../../../Login/LoginBox.aspx',680,460)">FAÇA LOGIN</a> <a>|</a>
                                                    <a href="/cadastro/" class="action-link criar-conta" style="font-size: 12px; font-family: Tahoma">CRIAR CONTA</a> <a>|</a>
                                                    <div><a class="forgot-password action-link" href="#" style="font-size: 12px; font-family: Tahoma;vertical-align: middle;display: inline-block" onclick="ExibirPopup('../../../../../../../../login/ForgotPassWord.aspx',450,290)">ESQUECI MINHA SENHA</a> </div>
                                                      
</div>
                                            </div>

                                            

                               
                                           
                                        </div>
                                             <!-- fim usuario não logado -->
                                        <div class="televendas col" style="margin-top: 20px;">
                                            <p><span>Televendas:</span> <strong>4007-2526</strong></p>
                                        </div>
                                        
                                            <div class="social col" style="margin-top: 15px;">

                                                <ul class="social-list">
                                                    <li class="social-item"><a href="https://www.facebook.com/DrogariaOnofreOficial" class="social-link facebook" target="_blank" title="Facebook">Facebook</a></li>
                                                    <li class="social-item"><a href="https://www.instagram.com/drogariaonofre/" class="social-link instagram" target="_blank" title="Instagram">Instagram</a></li>
                                                    <li class="social-item"><a href="https://blogonofre.wordpress.com/" class="social-link beonofre" target="_blank" title="BlogOnofre">BeOnofre</a></li>
                                                    
                                                </ul>
                                            </div>
                                    </div>
                                </div>
                                <!-- /topbar -->
                                <div class="wrapper full">
                                    <div class="menu-responsive col" onclick="openNavMobile()"> </div>
                                    <div class="logo col">
                                        <h1>  <a href="https://www.onofre.com.br/" class="logo-img">Onofre</a>  </h1> </div>
                                    <div class="cart-responsive">
                                        <div class="cart col"> <a href="/carrinho" class="go-to-cart"><span class="total-value"> <span id="lblCartTotalResponsive">R$ 0,00</span> </span></a> </div>
                                    </div>
                                    <div class="search col">
                                        <div class="msg-cvs">
                                            <p> <img src="https://www.onofre.com.br/assets/img/cvs-health-logo.jpg" alt="CVS Health" width="105" height="21" /> A drogaria onofre agora faz parte da rede de farmácias CVS Health. <a href="https://www.onofre.com.br/Institucional/Default.aspx?InstId=230" class="action-link">Clique aqui e saiba mais.</a> </p>
                                        </div>
                                        <!-- /search -->
                                        <div class="search-box">
                                            <!-- search box starts here -->
                                            
                                         
                                             <div id="pnBuscaSli">
	
                                                <input type="hidden" name="asug"  />
                                                <input name="ctl00$sli_search_1" type="text" id="sli_search_1" data-provide="rac" value="Digite o nome do produto, marca ou princípio ativo..." class="search-field search-input" data-sli-test="searchbox" onblur="if(value==&#39;&#39;)value=&#39;Digite o nome do produto, marca ou princípio ativo...&#39;" onfocus="if(value==&#39;Digite o nome do produto, marca ou princípio ativo...&#39;)value=&#39;&#39;" onkeydown="javascript:return fnTrapKD(event,this)" autocomplete="off" /> <a id="btnOkSli" class="search-icon" href="javascript:SliSearchById('sli_search_1')" data-sli-test="searchbutton">Ok</a> 
</div>
                                          <!-- search box ends here -->
                                        </div>
                                    </div>
                                    <!-- /search -->
                                    <!-- carrinho -->
                                    <div class="cart col cart-normal"> <a href="/carrinho" class="go-to-cart"><span class="total-value"> <span id="lblShoppingCartTotal">R$ 0,00</span> </span></a>
                                        <div class="cart-hover">
                                            <div id="CartPopUp" class="cart-list">
                                                 </div>
                                            <div class="cart-bottom">
                                                <div class="line" style="display:none">
                                                     <span class="total">Total: <strong class="total-value"> <span id="lblCartTotal">R$ 0,00</span></strong></span>
                                                </div>
                                                <div class="line">
                                                    <!--<div class="one-click"><a href="" class="btn btn-gray buy-one-click">Comprar com 1 clique</a></div>-->
                                                    <div class="buy-cart"><a href="/carrinho" class="btn btn-green">Finalizar compra</a> </div>
                                                </div>
                                            </div> <span id="lblProdAdicionado" class="prod-added">Produto adicionado ao carrinho</span> </div>
                                    </div>
                                </div>
                                
                            </header>
        <nav id="main-nav" class="page-nav">
                                <div class="wrapper full">
                                    <ul class="nav-list">
                                        
                                        <li class="nav-item medicamentos-e-saude"><a href='https://www.onofre.com.br' title='Medicamentos e Saúde' class='nav-link'>Medicamentos</a>
                                            <div class="sub-nav" style="z-index:5003">
                                                <ul class='medi-sub-nav-col'><li class='medi-sub-nav-item-titulo'><p>Intestino e Digestão</p></li><li class='medi-sub-nav-item'><a href='/medicamentos/saude-digestiva/44/03' class='medi-sub-nav-link' >Saúde Digestiva</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/antiflatulento/54/03' class='medi-sub-nav-link' >Antiflatulento</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/antiacido/95/03' class='medi-sub-nav-link' >Antiácido</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/laxante/248/03' class='medi-sub-nav-link' >Laxante</a></li><li class='medi-sub-nav-item'><a href='/medicamento/55/01' class='medi-sub-nav-link-vejamais' >(+) Veja Mais</a></li></ul><ul class='medi-sub-nav-col'><li class='medi-sub-nav-item-titulo'><p>Diabetes</p></li><li class='medi-sub-nav-item'><a href='/medicamentos/hipoglicemiante/234/03' class='medi-sub-nav-link' >Hipoglicemiante</a></li><li class='medi-sub-nav-item'><a href='/medicamento/55/01' class='medi-sub-nav-link-vejamais' >(+) Veja Mais</a></li></ul><ul class='medi-sub-nav-col'><li class='medi-sub-nav-item-titulo'><p>Hormônios</p></li><li class='medi-sub-nav-item'><a href='/medicamentos/antigotoso/57/03' class='medi-sub-nav-link' >Antigotoso</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/tireoidiano/342/03' class='medi-sub-nav-link' >Tireoidiano</a></li><li class='medi-sub-nav-item'><a href='/medicamento/55/01' class='medi-sub-nav-link-vejamais' >(+) Veja Mais</a></li></ul><ul class='medi-sub-nav-col'><li class='medi-sub-nav-item-titulo'><p>Infecções</p></li><li class='medi-sub-nav-item'><a href='/medicamentos/antibiotico/32/03' class='medi-sub-nav-link' >Antibiótico</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/anti-infeccioso/67/03' class='medi-sub-nav-link' >Anti-infeccioso</a></li><li class='medi-sub-nav-item'><a href='/medicamento/55/01' class='medi-sub-nav-link-vejamais' >(+) Veja Mais</a></li></ul><ul class='medi-sub-nav-col'><li class='medi-sub-nav-item-titulo'><p>Aparelho Urinário</p></li><li class='medi-sub-nav-item'><a href='/medicamentos/antidiuretico/46/03' class='medi-sub-nav-link' >Antidiurético</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/antilitiasico/80/03' class='medi-sub-nav-link' >Antilitiásico</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/diuretico/190/03' class='medi-sub-nav-link' >Diurético</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/incontinencia-urinaria/242/03' class='medi-sub-nav-link' >Incontinência Urinária</a></li><li class='medi-sub-nav-item'><a href='/medicamento/55/01' class='medi-sub-nav-link-vejamais' >(+) Veja Mais</a></li></ul><ul class='medi-sub-nav-col'><li class='medi-sub-nav-item-titulo'><p>Sistema Nervoso</p></li><li class='medi-sub-nav-item'><a href='/medicamentos/antivertiginoso/112/03' class='medi-sub-nav-link' >Antivertiginoso</a></li><li class='medi-sub-nav-item'><a href='/homeopaticos/calmante/147/03' class='medi-sub-nav-link' >Calmante</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/disturbio-do-tubo-neural/188/03' class='medi-sub-nav-link' >Distúrbio do Tubo Neural</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/neuropsicoestimulante/278/03' class='medi-sub-nav-link' >Neuropsicoestimulante</a></li><li class='medi-sub-nav-item'><a href='/medicamento/55/01' class='medi-sub-nav-link-vejamais' >(+) Veja Mais</a></li></ul><ul class='medi-sub-nav-col'><li class='medi-sub-nav-item-titulo'><p>Gripe e Resfriado</p></li><li class='medi-sub-nav-item'><a href='/medicamentos/antitussigenos/109/03' class='medi-sub-nav-link' >Antitussígenos</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/descongestionante/179/03' class='medi-sub-nav-link' >Descongestionante</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/irritacoes-da-garganta/246/03' class='medi-sub-nav-link' >Irritações da Garganta</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/expectorante-e-mucolitico/274/03' class='medi-sub-nav-link' >Expectorante e Mucolítico</a></li><li class='medi-sub-nav-item'><a href='/medicamento/55/01' class='medi-sub-nav-link-vejamais' >(+) Veja Mais</a></li></ul><ul class='medi-sub-nav-col'><li class='medi-sub-nav-item-titulo'><p>Anti-Hipertensivo</p></li><li class='medi-sub-nav-item'><a href='/medicamentos/antiarritmico/27/03' class='medi-sub-nav-link' >Antiarritmico</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/anti-hipertensivo/62/03' class='medi-sub-nav-link' >Anti-hipertensivo</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/cardiotonico/149/03' class='medi-sub-nav-link' >Cardiotônico</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/hipertensor/231/03' class='medi-sub-nav-link' >Hipertensor</a></li><li class='medi-sub-nav-item'><a href='/medicamento/55/01' class='medi-sub-nav-link-vejamais' >(+) Veja Mais</a></li></ul><ul class='medi-sub-nav-col'><li class='medi-sub-nav-item-titulo'><p>Cuidado com os Olhos</p></li><li class='medi-sub-nav-item'><a href='/medicamentos/orgaos-sensoriais/56/03' class='medi-sub-nav-link' >Órgãos Sensoriais</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/descongestionante-ocular/180/03' class='medi-sub-nav-link' >Descongestionante Ocular</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/distrofia-do-globo-ocular/189/03' class='medi-sub-nav-link' >Distrofia do Globo Ocular</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/lubrificante-ocular/260/03' class='medi-sub-nav-link' >Lubrificante Ocular</a></li><li class='medi-sub-nav-item'><a href='/medicamento/55/01' class='medi-sub-nav-link-vejamais' >(+) Veja Mais</a></li></ul><ul class='medi-sub-nav-col'><li class='medi-sub-nav-item-titulo'><p>Sistema Circulatório</p></li><li class='medi-sub-nav-item'><a href='/medicamentos/antianemico/26/03' class='medi-sub-nav-link' >Antianêmico</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/anti-hemorragico/61/03' class='medi-sub-nav-link' >Anti-hemorrágico</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/antivaricoso/111/03' class='medi-sub-nav-link' >Antivaricoso</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/hemostatico/221/03' class='medi-sub-nav-link' >Hemostático</a></li><li class='medi-sub-nav-item'><a href='/medicamento/55/01' class='medi-sub-nav-link-vejamais' >(+) Veja Mais</a></li></ul><ul class='medi-sub-nav-col'><li class='medi-sub-nav-item-titulo'><p>Vermes e Parasitas</p></li><li class='medi-sub-nav-item'><a href='/medicamentos/antifungico/52/03' class='medi-sub-nav-link' >Antifúngico</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/antimalarico/81/03' class='medi-sub-nav-link' >Antimalárico</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/antiparasitario/90/03' class='medi-sub-nav-link' >Antiparasitário</a></li><li class='medi-sub-nav-item'><a href='/medicamento/55/01' class='medi-sub-nav-link-vejamais' >(+) Veja Mais</a></li></ul><ul class='medi-sub-nav-col'><li class='medi-sub-nav-item-titulo'><p>Dor e Febre</p></li><li class='medi-sub-nav-item'><a href='/medicamentos/analgesico/8/03' class='medi-sub-nav-link' >Analgésico</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/anestesico/13/03' class='medi-sub-nav-link' >Anestésico</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/antienxaquecoso/48/03' class='medi-sub-nav-link' >Antienxaquecoso</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/anti-inflamatorio/69/03' class='medi-sub-nav-link' >Anti-inflamatório</a></li><li class='medi-sub-nav-item'><a href='/medicamento/55/01' class='medi-sub-nav-link-vejamais' >(+) Veja Mais</a></li></ul><ul class='medi-sub-nav-col'><li class='medi-sub-nav-item-titulo'><p>Alergias</p></li><li class='medi-sub-nav-item'><a href='/medicamentos/antialergico/21/03' class='medi-sub-nav-link' >Antialérgico</a></li><li class='medi-sub-nav-item'><a href='/medicamento/55/01' class='medi-sub-nav-link-vejamais' >(+) Veja Mais</a></li></ul><ul class='medi-sub-nav-col'><li class='medi-sub-nav-item-titulo'><p>Sistema Respiratório</p></li><li class='medi-sub-nav-item'><a href='/medicamentos/antiasmatico/29/03' class='medi-sub-nav-link' >Antiasmático</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/broncodilatador/142/03' class='medi-sub-nav-link' >Broncodilatador</a></li><li class='medi-sub-nav-item'><a href='/medicamento/55/01' class='medi-sub-nav-link-vejamais' >(+) Veja Mais</a></li></ul><ul class='medi-sub-nav-col'><li class='medi-sub-nav-item-titulo'><p>Pele e Mucosa</p></li><li class='medi-sub-nav-item'><a href='/medicamentos/cicatrizante/155/03' class='medi-sub-nav-link' >Cicatrizante</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/despigmentante/182/03' class='medi-sub-nav-link' >Despigmentante</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/aftas/215/03' class='medi-sub-nav-link' >Aftas</a></li><li class='medi-sub-nav-item'><a href='/tratamento-rosto/antiacne/399/03' class='medi-sub-nav-link' >Antiacne</a></li><li class='medi-sub-nav-item'><a href='/medicamento/55/01' class='medi-sub-nav-link-vejamais' >(+) Veja Mais</a></li></ul><ul class='medi-sub-nav-col'><li class='medi-sub-nav-item-titulo'><p>Vitaminas e Suplementos</p></li><li class='medi-sub-nav-item'><a href='/medicamentos/antifadiga/53/03' class='medi-sub-nav-link' >Antifadiga</a></li><li class='medi-sub-nav-item'><a href='/nutricosmeticos/antioxidante/88/03' class='medi-sub-nav-link' >Antioxidante</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/orexigeno/281/03' class='medi-sub-nav-link' >Orexígeno</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/vitaminico/367/03' class='medi-sub-nav-link' >Vitamínico</a></li><li class='medi-sub-nav-item'><a href='/medicamento/55/01' class='medi-sub-nav-link-vejamais' >(+) Veja Mais</a></li></ul><ul class='medi-sub-nav-col'><li class='medi-sub-nav-item-titulo'><p>Saúde Masculina</p></li><li class='medi-sub-nav-item'><a href='/medicamentos/antialopecia/20/03' class='medi-sub-nav-link' >Antialopécia</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/antiandrogenico/24/03' class='medi-sub-nav-link' >Antiandrogénico</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/disfuncao-eretil/185/03' class='medi-sub-nav-link' >Disfunção Erétil</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/hiperplasia-prostatica-benigna/230/03' class='medi-sub-nav-link' >Hiperplasia Prostática Benigna</a></li><li class='medi-sub-nav-item'><a href='/medicamento/55/01' class='medi-sub-nav-link-vejamais' >(+) Veja Mais</a></li></ul><ul class='medi-sub-nav-col'><li class='medi-sub-nav-item-titulo'><p>Saúde Feminina</p></li><li class='medi-sub-nav-item'><a href='/medicamentos/anticoncepcionais/39/03' class='medi-sub-nav-link' >Anticoncepcionais</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/disturbio-do-ciclo-menstrual/187/03' class='medi-sub-nav-link' >Distúrbio do Ciclo Menstrual</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/indutor-da-ovulacao/243/03' class='medi-sub-nav-link' >Indutor da Ovulação</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/terapeutica-da-menopausa/337/03' class='medi-sub-nav-link' >Terapêutica da Menopausa</a></li><li class='medi-sub-nav-item'><a href='/medicamento/55/01' class='medi-sub-nav-link-vejamais' >(+) Veja Mais</a></li></ul><ul class='medi-sub-nav-col'><li class='medi-sub-nav-item-titulo'><p>Sistema Ósseo</p></li><li class='medi-sub-nav-item'><a href='/medicamentos/antiartrosico/28/03' class='medi-sub-nav-link' >Antiartrósico</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/antiosteoporotico/87/03' class='medi-sub-nav-link' >Antiosteoporótico</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/osteoporose/94/03' class='medi-sub-nav-link' >Osteoporose</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/repositor-de-potassio/315/03' class='medi-sub-nav-link' >Repositor de Potássio</a></li><li class='medi-sub-nav-item'><a href='/medicamento/55/01' class='medi-sub-nav-link-vejamais' >(+) Veja Mais</a></li></ul><ul class='medi-sub-nav-col'><li class='medi-sub-nav-item-titulo'><p>Controle Especial</p></li><li class='medi-sub-nav-item'><a href='/medicamentos/antidepressivo/42/03' class='medi-sub-nav-link' >Antidepressivo</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/antiparkinsoniano/91/03' class='medi-sub-nav-link' >Antiparkinsoniano</a></li><li class='medi-sub-nav-item'><a href='/medicamento/55/01' class='medi-sub-nav-link-vejamais' >(+) Veja Mais</a></li></ul><ul class='medi-sub-nav-col'><li class='medi-sub-nav-item-titulo'><p>Outros</p></li><li class='medi-sub-nav-item'><a href='/medicamentos/antineoplasico/84/03' class='medi-sub-nav-link' >Antineoplásico</a></li><li class='medi-sub-nav-item'><a href='/medicamentos/antitabagismo/103/03' class='medi-sub-nav-link' >Antitabagismo</a></li><li class='medi-sub-nav-item'><a href='/medicamento/55/01' class='medi-sub-nav-link-vejamais' >(+) Veja Mais</a></li></ul>
                                                     </div>
                                        </li>
                                        <li class="nav-item medicamentos-e-saude_new"><a href='https://www.onofre.com.br' title='Medicamentos e Saúde' class='nav-link'>Saúde</a>
                                            <div class="sub-nav" style="z-index:5003">
                                                <ul class="sub-nav-col">
                                                    <li class='sub-nav-item'><a href='/geriatria/46/01' class='sub-nav-link' title='Geriatria'>Geriatria</a></li><li class='sub-nav-item'><a href='/higiene-e-limpeza/48/01' class='sub-nav-link' title='Higiene e Limpeza'>Higiene e Limpeza</a></li><li class='sub-nav-item'><a href='/homeopaticos/50/01' class='sub-nav-link' title='Homeopáticos'>Homeopáticos</a></li><li class='sub-nav-item'><a href='/alimentos-e-bebidas/52/01' class='sub-nav-link' title='Alimentos e Bebidas'>Alimentos e Bebidas</a></li><li class='sub-nav-item'><a href='/medicamentos/55/01' class='sub-nav-link' title='Medicamentos'>Medicamentos</a></li><li class='sub-nav-item'><a href='/cuidado-com-os-olhos/57/01' class='sub-nav-link' title='Cuidado com os Olhos'>Cuidado com os Olhos</a></li><li class='sub-nav-item'><a href='/ortopedia-e-acessorios/58/01' class='sub-nav-link' title='Ortopedia e Acessórios'>Ortopedia e Acessórios</a></li><li class='sub-nav-item'><a href='/primeiros-socorros/60/01' class='sub-nav-link' title='Primeiros Socorros'>Primeiros Socorros</a></li><li class='sub-nav-item'><a href='/sexo-seguro/61/01' class='sub-nav-link' title='Sexo Seguro'>Sexo Seguro</a></li><li class='sub-nav-item'><a href='/fitness-e-dietas/62/01' class='sub-nav-link' title='Fitness e Dietas'>Fitness e Dietas</a></li><li class='sub-nav-item'><a href='/testes-e-aparelhos/63/01' class='sub-nav-link' title='Testes e Aparelhos'>Testes e Aparelhos</a></li><li class='sub-nav-item'><a href='/vitaminas-e-naturais/65/01' class='sub-nav-link' title='Vitaminas e Naturais'>Vitaminas e Naturais</a></li>
                                                </ul>
                                                <div class="banner-menu">
                                                    <a id="A1"> <img id="Img1" /></a>
                                                    > </div>
                                            </div>
                                        </li>
                                        <li class="nav-item beleza-e-bem-estar"><a href='https://www.onofre.com.br' title='Beleza e Bem Estar' class='nav-link'>Beleza e Bem estar</a>
                                            <div class="sub-nav" style="z-index:5003">
                                                <ul class="sub-nav-col">
                                                    <li class='sub-nav-item'><a href='/tratamento-rosto/39/01' class='sub-nav-link' title='Tratamento Rosto'>Tratamento Rosto</a></li><li class='sub-nav-item'><a href='/cabelos/40/01' class='sub-nav-link' title='Cabelos'>Cabelos</a></li><li class='sub-nav-item'><a href='/corpo-e-banho/42/01' class='sub-nav-link' title='Corpo e Banho'>Corpo e Banho</a></li><li class='sub-nav-item'><a href='/cuidados-femininos/44/01' class='sub-nav-link' title='Cuidados Femininos'>Cuidados Femininos</a></li><li class='sub-nav-item'><a href='/cuidados-masculinos/49/01' class='sub-nav-link' title='Cuidados Masculinos'>Cuidados Masculinos</a></li><li class='sub-nav-item'><a href='/maos-e-pes/53/01' class='sub-nav-link' title='Mãos e Pés'>Mãos e Pés</a></li><li class='sub-nav-item'><a href='/maquiagem/54/01' class='sub-nav-link' title='Maquiagem'>Maquiagem</a></li><li class='sub-nav-item'><a href='/nutricosmeticos/56/01' class='sub-nav-link' title='Nutricosméticos'>Nutricosméticos</a></li><li class='sub-nav-item'><a href='/colonias/59/01' class='sub-nav-link' title='Colônias'>Colônias</a></li><li class='sub-nav-item'><a href='/tratamento-do-corpo/64/01' class='sub-nav-link' title='Tratamento do Corpo'>Tratamento do Corpo</a></li><li class='sub-nav-item'><a href='/higiene-bucal/68/01' class='sub-nav-link' title='Higiene Bucal'>Higiene Bucal</a></li><li class='sub-nav-item'><a href='/protecao-solar/69/01' class='sub-nav-link' title='Proteção Solar'>Proteção Solar</a></li>
                                                </ul>
                                                <div class="banner-menu">
                                                    <a id="banner_menu_p2"> <img id="banner_menu_img2" /></a>
                                                     </div>
                                            </div>
                                        </li>
                                        <li class="nav-item mamae-e-bebe"><a href='https://www.onofre.com.br' title='Mamãe e Bebê' class='nav-link'>Mamãe e Bebê</a>
                                            <div class="sub-nav" style="z-index:5003">
                                                <ul class="sub-nav-col">
                                                    <li class='sub-nav-item'><a href='/acessorios-infantis/37/01' class='sub-nav-link' title='Acessórios Infantis'>Acessórios Infantis</a></li><li class='sub-nav-item'><a href='/alimentos-infantis/38/01' class='sub-nav-link' title='Alimentos Infantis'>Alimentos Infantis</a></li><li class='sub-nav-item'><a href='/corpo-e-banho-infantil/41/01' class='sub-nav-link' title='Corpo e Banho Infantil'>Corpo e Banho Infantil</a></li><li class='sub-nav-item'><a href='/cuidados-com-a-mamae/43/01' class='sub-nav-link' title='Cuidados com a Mamãe'>Cuidados com a Mamãe</a></li><li class='sub-nav-item'><a href='/troca-de-fraldas/45/01' class='sub-nav-link' title='Troca de Fraldas'>Troca de Fraldas</a></li><li class='sub-nav-item'><a href='/cuidado-bucal-infantil/47/01' class='sub-nav-link' title='Cuidado Bucal Infantil'>Cuidado Bucal Infantil</a></li>
                                                </ul>
                                                <div class="banner-menu">
                                                    <a id="banner_menu_p3"> <img id="banner_menu_img3" /></a>
                                                     </div>
                                            </div>
                                        </li>
                                        <li class="nav-item ofertas-e-lancamentos"><a href='https://www.onofre.com.br' title ='Ofertas e Lançamentos' class='nav-link'>&nbsp&nbsp Ofertas e &nbsp&nbsp&nbsp&nbsp&nbsp<br /> &nbsp&nbsp Lançamentos</a>
                                            <div class="sub-nav" style="z-index:5003">
                                                <ul class="sub-nav-col">
                                                    <li class="sub-nav-item"><a href="/Produtos/OfertasLancamentos/oferta/66" class="sub-nav-link" title="Ofertas">Ofertas</a></li>
                                                </ul>
                                                <ul class="sub-nav-col">
                                                    <li class="sub-nav-item"><a href="/Produtos/OfertasLancamentos/lancamento/66" class="sub-nav-link" title="Lançamentos">Lançamentos</a></li>
                                                </ul>
                                                <div class="banner-menu">
                                                    <a id="banner_menu_p4"> <img id="banner_menu_img4" /></a>
                                                     </div>
                                            </div>
                                        </li>
                                        <li class="nav-item como-comprar"><a href='https://www.onofre.com.br/Institucional/Default.aspx?InstId=251' title='Como Comprar' class='nav-link'>Como Comprar</a></li>
                                    </ul>
                                </div>
                            </nav>
        <div class="float-bar"></div>
        
        <!-- /floatbar -->
        <!-- FIM HEADER -->
        <!-- ESTRUTURA -->
        <div class="page-content">
            <div class="wrapper">
                <!-- conteudo -->
                
    <script>
  window.fbAsyncInit = function() {
    FB.init({
      appId      : '333327017122265',
      xfbml      : true,
      version    : 'v2.8'
    });
    FB.AppEvents.logPageView();
  };
</script>
    <!-- Load Facebook SDK for JavaScript -->
    <div id="fb-root"></div>
    <script>(function(d, s, id) {
      var js, fjs = d.getElementsByTagName(s)[0];
      if (d.getElementById(id)) return;
      js = d.createElement(s); js.id = id;
      js.src = "https://connect.facebook.net/pt_BR/sdk.js#xfbml=1&version=v2.8";
      fjs.parentNode.insertBefore(js, fjs);
    }(document, 'script', 'facebook-jssdk'));</script>

    <div class="page-content">
        <div class="wrapper">
            <input type="hidden" name="ctl00$cphConteudo$url" id="url" />
            <input type="hidden" name="ctl00$cphConteudo$hdAtivo" id="hdAtivo" />
            <ul class="breadcrumb full">
                <div id="breadcrumbs">
                    <a href="/Default.aspx">Drogaria Onofre</a> &#62; <a href=/medicamentos/55/01 class="bread_beleza">Medicamentos</a> &#62; <a href=/medicamentos/antiparkinsoniano/91/03 class="bread_beleza">Antiparkinsoniano</a>

                </div>
            </ul>
            <div class="main-product-image col9">
                <div class="main-image-wrap">
                    <!-- SELO PRODUTO -->
                    <div id="cphConteudo_seloProduto" style="background:white;border-radius:5px;color:white;text-align:center;">selo produto</div>
                    <!-- FIM SELO PRODUTO -->
                    <a href="https://www.onofre.com.br/estatico/Produto/Super/" id="cphConteudo_linkimgGrande" class="jqzoom" rel="gal1" title="">
                        <img id="cphConteudo_imgGrande" alt="Prolopa Dispersível 100/25mg 30 Comprimidos" src="https://www.onofre.com.br/img/Busca/imagem_prescricao.jpg" height="480" width="480" />
                    </a></div>
                <input type="hidden" name="ctl00$cphConteudo$hf_id_produto" id="cphConteudo_hf_id_produto" value="32768" />
                <div class="img-thumbs">
                    <ul class="thumbs-list">
                        
                    </ul>
                </div>
            </div>
            <div class="main-product-info col7">
                <div class="flags"><span class="flag entrega-4horas">
                    </span> <span class="flag uso-adulto">
                        </span> </div>
                <div class="top-infos">
                    
                    <span class="code col">
                        <span id="cphConteudo_lblCode">Cód: 124338</span></span> <span class="ms col">
                            <span id="cphConteudo_num_registro"> MS: 1010000640126</span></span> </div>
                <h1 class="main-product-name">
                    <input type="hidden" name="ctl00$cphConteudo$ProductId" id="cphConteudo_ProductId" value="32768" />
                    <span id="lblProductName">Prolopa Dispersível 100/25mg 30 Comprimidos</span></h1>
                
                <span id="cphConteudo_produtoAntibioticoAviso"></span>
                <span id="cphConteudo_listaProdutoAntbiotico"></span>
                <div class="top-infos">
                    <span id="cphConteudo_lblProductManufacturer"><a class="fabricante2" href="">Roche Quimicos</a></span>
                </div>
                <div class="product-spec">
                    <div id="DtlprinAtivo" class="spec principio-ativo">
                        <p class="spec-title col2">Princípio Ativo </p>
                        <p class="spec-text col5">
                            <span id="cphConteudo_lblDescriptionResume">Levedopa+Cloridrato de Benserazida</span>
                        </p>
                    </div>
                    
                    
                    
                    <a href="https://www.onofre.com.br/estatico/Bula/124338.pdf" id="bulaDetalhe" class="view-bula" target="_blank">Visualizar Bula do medicamento</a>
                    <div class="action-box">
                        
                        <div class="col3 dinheiro-extra" style="position: relative; margin-top: 10px;">
                            <div class="fb-save" data-uri="http://www.onofre.com.br/DetalheProduto/Default.aspx?ProductName=prolopa-dispersivel-10025mg-30-comprimidos&ProductId=32768" data-size="small"></div>
                            
                            
                            <div id="cphConteudo_divSemPBM" style="margin-top: -10px;"><small class="aviso">Preço válido para compras feitas pela internet. Imagem meramente ilustrativa.</small>
                                <!-- Campo CRM para medicamentos -->
                                <div id="cphConteudo_divCRM">
                                    <span id="cphConteudo_lblCrm">Insira o CRM do Médico:</span>
                                    <input name="ctl00$cphConteudo$txtCrm" type="text" id="cphConteudo_txtCrm" style="width: 100px; padding-bottom: -110px;" />&nbsp;
                                    <select name="ctl00$cphConteudo$slCrmUF" id="cphConteudo_slCrmUF" onchange="ValidarSelectCRM(this)">
	<option selected="selected" value="SP" disabled="">UF</option>
	<option value="AC">AC</option>
	<option value="AL">AL</option>
	<option value="AP">AP</option>
	<option value="AM">AM</option>
	<option value="BA">BA</option>
	<option value="CE">CE</option>
	<option value="DF">DF</option>
	<option value="ES">ES</option>
	<option value="GO">GO</option>
	<option value="MA">MA</option>
	<option value="MS">MS</option>
	<option value="MT">MT</option>
	<option value="MG">MG</option>
	<option value="PA">PA</option>
	<option value="PB">PB</option>
	<option value="PR">PR</option>
	<option value="PE">PE</option>
	<option value="PI">PI</option>
	<option value="RJ">RJ</option>
	<option value="RN">RN</option>
	<option value="RS">RS</option>
	<option value="RO">RO</option>
	<option value="RR">RR</option>
	<option value="SC">SC</option>
	<option value="SP">SP</option>
	<option value="SE">SE</option>
	<option value="TO">TO</option>
</select>
                                </div>
                                <!-- Fim Campo CRM para Medicamentos -->
                                <em>
                                    <span id="cphConteudo_lblMsg">Venda sob prescrição médica.</span></em> </div>

                            
                            <div id="divDescricaoDermaClub" onclick="$(this).hide();" style="width: 100%; height: 100%; position: fixed; top: 0; left: 0; background-color: rgba(255,255,255,0.6); padding-top: 10%; display: none; z-index: 5">
                                <div style="background-color: #99CCFF; border: 2px dashed #00B0F0; width: 500px; height: 250px; margin: 0 auto; color: white; font-weight: bold; z-index: 5; font-size: 19px; padding-top: 10px;"><span style="margin: 0 auto; width: 95%; display: block;">"O DermaClub é o clube de vantagens das marcas<br />
                                    La Roche-Posay, Vichy e SkinCeuticals, onde você pode acumular pontos em todas as suas compras e trocar por descontos e benefícios exclusivos. Além disso, você recebe dicas personalizadas sobre sua pele dos maiores dermatologistas do Brasil. Junte-se a nós e aproveite o máximo de vantagens para você e sua pele. Cadastre-se em <a style="text-decoration: none; color: white;" target="_blank" href="https://www.dermaclub.com.br">www.dermaclub.com.br</a>" </span></div>
                            </div>
                            <!--<div id="cphConteudo_divSeloDermaclu" onclick="window.open(&#39;/loginloreal.aspx&#39;,&#39;_self&#39;);" style="width: 225px; height: 115px; background-color: #FF7C80; padding-left: 4px; padding-right: 4px; padding-top: 4px; position: absolute; left: -65px; margin-top: 50px;">
                                <div style="background-color: white; width: 217px; height: 75px;">
                                    <div style="margin: 0 auto; width: 65%; padding-top: 12px;">
                                        <img style="float: left; margin-right: 4px;" alt="Promoção" height="24" src="/~/img/DetalheProduto/icone-medalha.png" />
                                        <img style="float: left; margin-right: 4px;" alt="DermaClub" height="13" src="/~/img/DetalheProduto/dermaclub-logo.png" />
                                        <div onmouseover="$('#divDescricaoDermaClub').show();" style="float: left; font-size: 10px; color: white; font-weight: 600; width: 12px; height: 12px; background-image: url('/~/img/DetalheProduto/interrogation-mark.png'); background-size: cover;"></div>
                                        <div style="float: left; font-size: 7px; font-weight: 800">COMPRE & GANHE <span style="color: #5EB1D9">0 PONTOS</span></div>
                                    </div>
                                    <p align="center" style="font-family: Arial; font-weight: 900; color: black; font-size: 12px; padding-top: 15px;">Comprar com desconto</p>
                                </div>
                                <p id="cphConteudo_pDescontoPorcentagemDermaclub" align="center" style="color: white; font-weight: bold; font-size: 25px;"></p>
                            </div>-->

                            

                        </div>

                         
                        <div id="cphConteudo_divBuyArea" class="col4 buy-area">
                            <div id="cphConteudo_divDropQuantidade"><span class="group-title">Selecione a
                                <span id="cphConteudo_lblDescEspeci">Quantidade</span>:</span>
                                <div class="sku-radio"><span class="group-name">
                                    <span id="cphConteudo_lblDescEspeci1">Quantidade</span></span>
                                    <div class="sku-list">
                                        <ul>
                                            
                                                    <li class="sku-item"><a href="/prolopa-dispersivel-10025mg-30-comprimidos/32768/05" id="Urlfilhos"> 
                                                        <label class="sku-name" for="beach"> 
                                                            <img id="cphConteudo_rptProdutoFilhos_imgEspe_0" Border="0" src="https://www.onofre.com.br/estatico/produto/especificacao/410.jpg" height="40" width="40" />
                                                            <span>30 comprimidos</span> </label>
                                                    </a></li>
                                                
                                        </ul>
                                    </div>
                                </div>
                            </div>
                            
                            <div id="cphConteudo_main_product" class="main-product-price"><span>
                                <label></label>
                            </span><span id="cphConteudo_old_price_span" class="old-price"><em>
                                <span id="cphConteudo_lblPrecoDe">R$ 65,93</span></em></span>  <span class="regular-price">
                                    <span id="cphConteudo_lblPrecoPor">R$ 50,77</span></span> </div>
                            <div id="cphConteudo_divComprar" class="buy-product buy-page">
                                <div id="cphConteudo_botao_quantidade_antigo" class="qtd">
                                    <div class="controls"><span onclick="incrementValue()">+</span> <span onclick="DecrementValue()">-</span> </div>
                                    <input name="ctl00$cphConteudo$txt_QtdDP" type="text" id="txt_QtdDP" value="1" class="qtd-field" readonly="readonly" />
                                </div>
                                <a href="javascript:chamarAjaxQtd('AddItem','[{idProduct:32768}]',parent.document.getElementById('txt_QtdDP').value);" id="cphConteudo_btComprarDP" class="btn-green btn-buy" onclick="SalvarCRMProduto">Comprar</a> </div>

                               <!--Quando o produto for derma club vai mostra um banner
                                <div style="top: 49%;left: 50%;margin-left: -25px;margin-top: 4px">
                                 <br />
                                         
                                 <a href="/loginloreal.aspx">
                                   <img id="derma-detalhe" style="display:none"   class="img-responsive" alt="derma club" src="../../img/DetalheProduto/dermaclub-detalhe.png"/>
                                  </a>
                                </div>  
                            -->
                               <!--*******************************************************************************-->


                            
                            
                            
                        </div>
                        <div>



 
                            
                        </div>
                        
                        

                        

                    </div>
                </div>
            </div>
            <div class="complementary row">
                
                <div id="AnvisaEtiquetaTextoSemBorda" class="AnvisaEtiquetaTextoSemBorda">
                    
                    
                </div>







                   </div>
            <div class="ch_clear" chaordic="top"></div>
            <div class="product-details tabs row col12">
                <nav class="tab-nav">
                    
                    <h2 id="cphConteudo_divDescricao_tab" class="tab-item active" data-item="descricao">Descrição do Produto</h2>
                    
                    
                </nav>
                
                <div id="cphConteudo_divDescricao" class="tab-content descricao active">
                    <p>
                        <p align="justify"><span style="font-size: 10pt; color: #808080; font-family: Tahoma">&nbsp;<strong>Prolopa&#174; Roche<br />
</strong><br />
levodopa + cloridrato de benserazida <br />
<br />
Antiparkinsoniano <br />
<br />
IDENTIFICA&#199;&#195;O DO MEDICAMENTO <br />
Nome do produto: Prolopa&#174;<br />
Nome gen&#233;rico: levodopa + cloridrato de benserazida <br />
<br />
Formas farmac&#234;uticas, via de administra&#231;&#227;o e apresenta&#231;&#245;es <br />
Prolopa&#174; comprimidos 250 mg. Uso oral. Caixa com 30 comprimidos birranhurados. <br />
Prolopa&#174; HBS* c&#225;psulas 125 mg. Uso oral. Caixa com 30 c&#225;psulas. <br />
Prolopa&#174; comprimidos dispers&#237;veis 125 mg. Uso oral. Caixa com 30 comprimidos dispers&#237;veis. <br />
*HBS &#233; uma sigla adotada internacionalmente e significa Hydrodynamically Balanced System, uma apresenta&#231;&#227;o especial que propicia uma libera&#231;&#227;o prolongada das subst&#226;ncias ativas no est&#244;mago, onde a c&#225;psula de Prolopa&#174; HBS permanece por v&#225;rias horas. <br />
<br />
USO ADULTO <br />
<br />
Composi&#231;&#227;o <br />
Princ&#237;pio ativo: levodopa + cloridrato de benserazida. <br />
<br />
- Prolopa&#174; comprimidos 250 mg: cont&#233;m 200 mg de levodopa (L-dopa) e 57 mg de cloridrato de benserazida, correspondente a 50 mg de benserazida. <br />
Excipientes: manitol, fosfato de c&#225;lcio dib&#225;sico, celulose microcristalina, amido, povidona, estearato de magn&#233;sio, etilcelulose, &#243;xido de ferro vermelho, &#225;cido sil&#237;cico, dioctilsulfosuccinato de s&#243;dio. <br />
<br />
- Prolopa&#174; HBS* c&#225;psulas 125 mg: cont&#233;m 100 mg de levodopa (L-dopa) e 28,5 mg de cloridrato de benserazida, correspondente a 25 mg de benserazida. <br />
Excipientes: hipromelose, &#243;leo vegetal hidrogenado, fosfato de c&#225;lcio dib&#225;sico anidro, manitol, talco, povidona, estearato de magn&#233;sio. <br />
<br />
- Prolopa&#174; comprimidos dispers&#237;veis 125 mg: cont&#233;m 100 mg de levodopa (L-dopa) e 28,5 mg de cloridrato de benserazida, correspondente a 25 mg de benserazida. <br />
Excipientes: &#225;cido c&#237;trico anidro, amido pr&#233;-gelatinizado, celulose microcristalina, estearato de magn&#233;sio. <br />
<br />
INFORMA&#199;&#213;ES AO PACIENTE <br />
Solicitamos a gentileza de ler cuidadosamente as informa&#231;&#245;es abaixo. Caso n&#227;o esteja seguro a respeito de determinado item, favor informar ao seu m&#233;dico. <br />
<br />
1. A&#199;&#195;O DO MEDICAMENTO <br />
<br />
Prolopa&#174; &#233; uma associa&#231;&#227;o das subst&#226;ncias levodopa e cloridrato de benserazida, indicado para o tratamento de pacientes com doen&#231;a de Parkinson. A presen&#231;a da subst&#226;ncia benserazida ajuda a preservar o efeito terap&#234;utico da levodopa, al&#233;m de diminuir as suas rea&#231;&#245;es indesej&#225;veis. Prolopa&#174; HBS na forma c&#225;psula de 125 mg, libera gradativamente as subst&#226;ncias ativas no tubo digestivo, garantindo assim um efeito terap&#234;utico por tempo mais longo. Prolopa&#174; na forma comprimido dispers&#237;vel 125 mg libera as subst&#226;ncias ativas mais rapidamente e, portanto tem o in&#237;cio do efeito terap&#234;utico mais r&#225;pido. &#201; indicado para aqueles pacientes com dificuldades de degluti&#231;&#227;o ou que necessitem de um efeito terap&#234;utico mais r&#225;pido. <br />
<br />
2. INDICA&#199;&#213;ES DO MEDICAMENTO <br />
Prolopa&#174; &#233; indicado para o tratamento de pacientes com doen&#231;a de Parkinson. A forma farmac&#234;utica c&#225;psula (Prolopa&#174; HBS) &#233; adequada ao tratamento de pacientes parkisonianos que apresentam flutua&#231;&#245;es na resposta ao tratamento. As flutua&#231;&#245;es podem ser: movimentos involunt&#225;rios quando se tem maior concentra&#231;&#227;o das subst&#226;ncias ativas no organismo, isto &#233;, no pico de dose de um medicamento, ou dificuldades de movimenta&#231;&#227;o chamada tamb&#233;m de deterioro de final de dose como a imobilidade noturna ou pela manh&#227;, quando se tem menor concentra&#231;&#227;o das subst&#226;ncias ativas no organismo. A forma farmac&#234;utica comprimido dispers&#237;vel &#233; adequada para pacientes com dificuldades de degluti&#231;&#227;o ou pacientes que necessitem de um in&#237;cio de efeito terap&#234;utico mais r&#225;pido. <br />
<br />
3. RISCOS DO MEDICAMENTO <br />
<br />
Contra-indica&#231;&#245;es <br />
Prolopa&#174; n&#227;o deve ser utilizado durante a gravidez e lacta&#231;&#227;o, ou por crian&#231;as ou pacientes com menos de 25 anos; tamb&#233;m n&#227;o devem ser utilizados por pacientes que estejam tomando ou tenham tomado recentemente inibidores da monoaminoxidase, por pacientes com doen&#231;as graves dos rins, cora&#231;&#227;o, f&#237;gado ou gl&#226;ndulas end&#243;crinas, com glaucoma de &#226;ngulo fechado ou com hist&#243;ria anterior de algumas doen&#231;as psiqui&#225;tricas graves. Informe seu m&#233;dico sobre qualquer medicamento utilizado antes ou durante o tratamento. <br />
Deve-se ter cuidado especial em pacientes com antecedentes de doen&#231;as card&#237;acas ou pacientes diab&#233;ticos. Os pacientes com glaucoma de &#226;ngulo aberto devem ter a press&#227;o intra-ocular medida regularmente. Se estiver usando Prolopa&#174;, informe seu m&#233;dico caso tenha que se submeter a uma cirurgia. <br />
Prolopa&#174; n&#227;o deve ser utilizado por pacientes com conhecida hipersensibilidade &#224; levodopa, benserazida ou a qualquer componente da f&#243;rmula, como tamb&#233;m por pacientes com hist&#243;rico de &#250;lcera p&#233;ptica ou epis&#243;dios de convuls&#227;o. <br />
N&#227;o fa&#231;a uso deste medicamento sem prescri&#231;&#227;o e acompanhamento m&#233;dico. Pode ser que Prolopa&#174; n&#227;o seja indicado para seu caso, o que s&#243; seu m&#233;dico poder&#225; avaliar. Pela mesma raz&#227;o, n&#227;o ceda nem recomende este medicamento para outras pessoas. <br />
<br />
Advert&#234;ncias e Precau&#231;&#245;es <br />
Rea&#231;&#245;es de hipersensibilidade podem ocorrer em indiv&#237;duos pr&#233;-dispostos. <br />
Em pacientes com glaucoma de &#226;ngulo aberto, recomenda-se medir regularmente a press&#227;o intra-ocular, pois a levodopa teoricamente pode aumentar a press&#227;o intra-ocular. <br />
Depress&#227;o pode ser parte do quadro cl&#237;nico em pacientes com doen&#231;a de Parkinson e ainda pode ocorrer em pacientes tratados com Prolopa&#174;. <br />
Agita&#231;&#227;o, ansiedade, ins&#244;nia, alucina&#231;&#245;es, del&#237;rios e desorienta&#231;&#227;o temporal podem ocorrer particularmente em pacientes idosos e em pacientes com antecedentes psiqui&#225;tricos. <br />
Recomenda-se controle hematol&#243;gico e de fun&#231;&#227;o hep&#225;tica durante o tratamento. <br />
Em pacientes diab&#233;ticos, monitorar com regularidade a glicemia e fazer os ajustes necess&#225;rios na dose de hipoglicemiantes. <br />
Se o paciente em tratamento com levodopa necessitar de anestesia geral, a administra&#231;&#227;o de Prolopa&#174; deve ser continuada at&#233; a cirurgia, exceto no caso do halotano. Em anestesia geral com halotano deve-se descontinuar o uso de Prolopa&#174; 12 a 48 horas antes da interven&#231;&#227;o cir&#250;rgica, pois flutua&#231;&#245;es da press&#227;o arterial e/ou arritmias podem ocorrer. O tratamento com Prolopa&#174; pode ser retomado ap&#243;s a cirurgia, com reintrodu&#231;&#227;o gradual e eleva&#231;&#227;o da dose at&#233; o n&#237;vel posol&#243;gico anterior. <br />
Prolopa&#174; n&#227;o deve ser interrompido abruptamente. A interrup&#231;&#227;o abrupta pode produzir quadro semelhante a s&#237;ndrome maligna do neurol&#233;ptico, que se caracteriza por hiperpirexia, instabilidade auton&#244;mica, rigidez muscular acentuada e delirium, com poss&#237;veis altera&#231;&#245;es laboratoriais, incluindo aumento de creatinofosfoquinase (CPK), e pode ser fatal. Caso ocorram tais sinais ou sintomas, o paciente dever&#225; ser mantido em observa&#231;&#227;o m&#233;dica, se necess&#225;rio, hospitalizado, e receber tratamento sintom&#225;tico r&#225;pido e adequado, que pode incluir a reintrodu&#231;&#227;o de levodopa, ap&#243;s avalia&#231;&#227;o apropriada. <br />
Levodopa tem sido associado com sonol&#234;ncia e in&#237;cio de epis&#243;dios de sono repentino. <br />
In&#237;cio de epis&#243;dios de sono repentino durante as atividades do dia, em alguns casos sem sinais de aviso ou consci&#234;ncia, tem sido muito raramente reportado. Pacientes devem ser informados disso e aconselhados a ter precau&#231;&#227;o enquanto dirigem ou operam m&#225;quinas durante o tratamento com levodopa. <br />
<br />
Pacientes que tem sonol&#234;ncia comprovada e/ou in&#237;cio de epis&#243;dio repentino de sono devem privar-se de dirigir ou operar m&#225;quinas. Al&#233;m disso, uma redu&#231;&#227;o da dosagem ou t&#233;rmino da terapia deve ser considerada (vide item Efeitos sobre a capacidade de dirigir e operar m&#225;quinas). <br />
<br />
Medicamentos dopamin&#233;rgicos <br />
V&#237;cio em jogos de azar, libido aumentada e hipersexualidade t&#234;m sido relatados em pacientes tratados com agonistas da dopamina para Doen&#231;a de Parkinson. N&#227;o h&#225; rela&#231;&#227;o causal entre Prolopa&#174;, o qual n&#227;o &#233; um agonista da dopamina, e estes eventos. Entretanto, recomenda-se precau&#231;&#227;o, pois Prolopa&#174; &#233; um medicamento dopamin&#233;rgico. <br />
Potencial para depend&#234;ncia da droga ou abuso <br />
<br />
Um pequeno subgrupo de pacientes com doen&#231;a de Parkinson apresentou dist&#250;rbio cognitivo e comportamental que puderam ser diretamente atribu&#237;do ao aumento da quantidade de ingest&#227;o de medica&#231;&#227;o sem prescri&#231;&#227;o m&#233;dica e ao aumento das doses requeridas para tratar suas inabilidades motoras. <br />
<br />
Efeitos sobre a capacidade de dirigir e operar m&#225;quinas <br />
Pacientes tratados com levodopa e que apresentam sonol&#234;ncia e/ou in&#237;cio de epis&#243;dios de sono repentino devem ser advertidos para evitar dirigir ou se engajar em atividades nas quais a desaten&#231;&#227;o pode colocar eles ou outros em risco de ferimento grave ou morte (ex. operar m&#225;quinas) at&#233; que os epis&#243;dios recorrentes e sonol&#234;ncia sejam resolvidos. <br />
<br />
Uso em casos de insufici&#234;ncia renal <br />
Prolopa&#174; &#233; extensamente metabolizado e menos que 10% do levodopa &#233; excretado sem altera&#231;&#227;o pelos rins. Portanto no caso de insufici&#234;ncia renal leve ou moderada n&#227;o &#233; necess&#225;ria redu&#231;&#227;o de dose. <br />
Dados da farmacocin&#233;tica da levodopa em pacientes com insufici&#234;ncia renal n&#227;o est&#227;o dispon&#237;veis. Prolopa&#174; &#233; bem tolerado por pacientes ur&#234;micos passando por hemodi&#225;lise. <br />
<br />
Uso em casos de insufici&#234;ncia hep&#225;tica <br />
Levodopa &#233; metabolizada principalmente pela descarboxilase (amino&#225;cido arom&#225;tico) que est&#225; presente em abund&#226;ncia no trato intestinal, rim, cora&#231;&#227;o e tamb&#233;m no f&#237;gado. <br />
Dados da farmacocin&#233;tica da levodopa em pacientes com insufici&#234;ncia hep&#225;tica n&#227;o est&#227;o dispon&#237;veis. <br />
<br />
Intera&#231;&#245;es medicamentosas e alimentares <br />
Informe seu m&#233;dico sobre qualquer medicamento utilizado antes ou durante o tratamento. <br />
Observa-se redu&#231;&#227;o do efeito, quando Prolopa&#174; &#233; ingerido com uma refei&#231;&#227;o rica em prote&#237;nas. <br />
<br />
Intera&#231;&#245;es farmacocin&#233;ticas <br />
A administra&#231;&#227;o concomitante de anti&#225;cidos com Prolopa&#174; HBS reduz a extens&#227;o de absor&#231;&#227;o de levodopa em 32%. <br />
Sulfato ferroso reduz a concentra&#231;&#227;o plasm&#225;tica m&#225;xima e a &#225;rea sob a curva de levodopa em 30 a 50%. As altera&#231;&#245;es farmacocin&#233;ticas observadas durante a co-administra&#231;&#227;o de sulfato ferroso parecem ser clinicamente significantes em alguns, mas n&#227;o em todos os pacientes. <br />
A metoclopramida aumenta a velocidade de absor&#231;&#227;o de levodopa. <br />
N&#227;o h&#225; intera&#231;&#245;es farmacocin&#233;ticas entre a levodopa e os seguintes compostos: bromocriptina, amantadina, selegilina e domperidona. <br />
<br />
Intera&#231;&#245;es farmacodin&#226;micas <br />
Neurol&#233;pticos, opi&#243;ides e medicamentos antihipertensivos contendo reserpina inibem o efeito de Prolopa&#174;. <br />
Prolopa&#174; n&#227;o deve ser associado a inibidores da monoaminoxidase (IMAOs) n&#227;o-seletivos. Se Prolopa&#174; for administrado a pacientes em uso de IMAOs n&#227;o-seletivos, deve-se aguardar um intervalo m&#237;nimo de 2 semanas entre a interrup&#231;&#227;o do IMAO e o in&#237;cio do tratamento com levodopa. Caso contr&#225;rio, podem ocorrer efeitos adversos como crise hipertensiva. IMAOs-B seletivos, como a selegilina e rasagilina, e IMAOs-A seletivos, como a moclobemida, podem ser prescritos a pacientes em tratamento com Prolopa&#174;; recomenda-se reajustar as doses de levodopa, conforme as necessidades individuais dos pacientes, em termos de tolerabilidade e efic&#225;cia. A combina&#231;&#227;o de inibidores seletivos de MAO-A e MAO-B &#233; equivalente ao uso de IMAOs n&#227;o-seletivos, e n&#227;o dever&#225; ser usada com Prolopa&#174;. <br />
Prolopa&#174; n&#227;o deve ser administrado concomitantemente com simpatomim&#233;ticos como epinefrina, norepinefrina, isoproterenol ou anfetamina, pois a levodopa pode potencializar seus efeitos. Se houver necessidade de administra&#231;&#227;o concomitante, &#233; essencial monitora&#231;&#227;o rigorosa do sistema cardiovascular e pode ser necess&#225;ria redu&#231;&#227;o da dose do simpatomim&#233;tico. <br />
A associa&#231;&#227;o com outros produtos antiparkinsonianos como anticolin&#233;rgicos, amantadina e agonistas dopamin&#233;rgicos &#233; permitida; entretanto, tanto os efeitos desejados como os efeitos adversos podem ser intensificados, e pode ser necess&#225;ria redu&#231;&#227;o da dose de levodopa ou do outro antiparkinsoniano. Anticolin&#233;rgicos n&#227;o devem ser retirados abruptamente quando se iniciar o tratamento com Prolopa&#174;, pois o efeito da levodopa n&#227;o &#233; imediato. <br />
<br />
Gravidez e amamenta&#231;&#227;o <br />
<br />
Este medicamento n&#227;o deve ser utilizado por mulheres gr&#225;vidas sem orienta&#231;&#227;o m&#233;dica ou do cirurgi&#227;o-dentista. <br />
Prolopa&#174; n&#227;o deve ser utilizado por mulheres gr&#225;vidas ou com possibilidade de engravidar, na aus&#234;ncia de m&#233;todo anticoncepcional adequado. Se ocorrer gravidez durante tratamento com Prolopa&#174; o medicamento dever&#225; ser interrompido (conforme recomenda&#231;&#227;o m&#233;dica). <br />
M&#227;es que estejam amamentando: Como &#233; desconhecido se ocorre passagem de benserazida para o leite materno, m&#227;es em tratamento com Prolopa&#174; n&#227;o devem amamentar, pois h&#225; risco de ocorr&#234;ncia de malforma&#231;&#245;es do sistema esquel&#233;tico da crian&#231;a. <br />
<br />
Este medicamento &#233; de uso adulto. <br />
<br />
Informe ao m&#233;dico ou cirurgi&#227;o-dentista o aparecimento de rea&#231;&#245;es indesej&#225;veis. <br />
<br />
Informe ao seu m&#233;dico ou cirurgi&#227;o-dentista se voc&#234; est&#225; fazendo uso de algum outro medicamento. <br />
<br />
N&#227;o use medicamento sem o conhecimento do seu m&#233;dico. Pode ser perigoso para a sua sa&#250;de. <br />
<br />
4. MODO DE USO <br />
Sempre utilize Prolopa&#174; exatamente como seu m&#233;dico recomendou. N&#227;o mude, em hip&#243;tese alguma, as doses por sua conta. Pode ser prejudicial para sua sa&#250;de. <br />
<br />
Formas farmac&#234;uticas <br />
Prolopa&#174; comprimidos 250 mg. Comprimidos de forma cil&#237;ndrica biplanar, colora&#231;&#227;o vermelho p&#225;lido a fosco, gravado no lado superior ROCHE com hex&#225;gono e ranhura cruzada e no lado inferior Ranhura cruzada. <br />
Prolopa&#174; HBS* c&#225;psulas 125 mg. C&#225;psula com colora&#231;&#227;o azul claro opaco no corpo e verde escuro opaco na tampa, de superf&#237;cie limpa e contendo impress&#227;o ROCHE. <br />
Prolopa&#174; comprimidos dispers&#237;veis 125 mg. Comprimidos de forma cil&#237;ndrica biplanar, colora&#231;&#227;o branco a quase branco, gravado no lado superior ROCHE 125 e no lado inferior Ranhura n&#237;tida. <br />
Sempre que poss&#237;vel Prolopa&#174; deve ser tomado no m&#237;nimo 30 minutos antes ou 1 hora ap&#243;s as refei&#231;&#245;es. Os comprimidos de Prolopa&#174; dispers&#237;vel devem ser dissolvidos em um quarto de copo de &#225;gua; a solu&#231;&#227;o deve ser ingerida at&#233; 30 minutos ap&#243;s preparada. As c&#225;psulas de Prolopa&#174; HBS devem ser ingeridas sem mastigar. Se voc&#234; tiver algum tipo de intoler&#226;ncia gastrintestinal no in&#237;cio do tratamento com Prolopa&#174;, este pode, como alternativa, ser ingerido com um pequeno lanche (por exemplo, biscoitos) ou algum l&#237;quido. <br />
Pode ocorrer altera&#231;&#227;o na colora&#231;&#227;o da urina, passando, em geral, a avermelhada, e tornando-se mais escura, se guardada. <br />
<br />
Interrup&#231;&#227;o do tratamento <br />
Seu m&#233;dico sabe o momento ideal para interromper o tratamento. Quaisquer d&#250;vidas que surjam durante o tratamento com Prolopa&#174;. <br />
<br />
Siga a orienta&#231;&#227;o de seu m&#233;dico, respeitando sempre os hor&#225;rios, as doses e a dura&#231;&#227;o do tratamento. <br />
<br />
N&#227;o interrompa o tratamento sem o conhecimento do seu m&#233;dico. <br />
<br />
N&#227;o use o medicamento com o prazo de validade vencido. Antes de usar observe o aspecto do medicamento. <br />
<br />
Prolopa&#174; HBS c&#225;psulas: Este medicamento n&#227;o pode ser partido ou mastigado. <br />
<br />
5. REA&#199;&#213;ES ADVERSAS <br />
Prolopa&#174; em geral &#233; bem tolerado, mas eventualmente podem ocorrer efeitos indesejados, como n&#225;useas, v&#244;mitos, diarr&#233;ia, falta de apetite, altera&#231;&#245;es do paladar, movimentos involunt&#225;rios, altera&#231;&#245;es do ritmo card&#237;aco, redu&#231;&#227;o da press&#227;o arterial associada &#224; posi&#231;&#227;o, rea&#231;&#245;es cut&#226;neas (prurido ou rubor), anemia, ins&#244;nia, agita&#231;&#227;o ou epis&#243;dios depressivos com ou sem tend&#234;ncias suicidas, epis&#243;dios psic&#243;ticos, alucina&#231;&#245;es, del&#237;rios, angina pectoris, constipa&#231;&#227;o, flutua&#231;&#245;es na resposta terap&#234;utica durante tratamento prolongado com incapacidade tempor&#225;ria e involunt&#225;ria de movimento (freezing), efeitos de fim de dose, perda de peso e falta de ar. Estes efeitos podem ocorrer durante ou ap&#243;s o tratamento com Prolopa&#174;. Caso tenha qualquer rea&#231;&#227;o desagrad&#225;vel com o uso de Prolopa&#174;, comunique-se imediatamente com seu m&#233;dico. <br />
<br />
6. CONDUTA EM CASO DE SUPERDOSE <br />
Sinais e sintomas <br />
Os sinais e sintomas de superdose s&#227;o qualitativamente similares aos efeitos adversos de Prolopa&#174; em doses terap&#234;uticas, mas &#233; prov&#225;vel que sejam mais severos. Superdose pode levar a: efeitos adversos cardiovasculares (arritmia card&#237;aca), dist&#250;rbios psiqui&#225;tricos (confus&#227;o e ins&#244;nia), efeitos gastro-intestinais (n&#225;usea e v&#244;mitos) e movimentos involunt&#225;rios anormais. <br />
<br />
Tratamento <br />
Monitorar os sinais vitais do paciente e instituir medidas de suporte de acordo com o estado cl&#237;nico do paciente. Determinados pacientes podem necessitar de tratamento sintom&#225;tico para efeitos cardiovasculares (antiarr&#237;tmicos) ou efeitos no sistema nervoso central (estimulantes respirat&#243;rios, neurol&#233;pticos).00 <br />
Al&#233;m disso, para formula&#231;&#245;es de libera&#231;&#227;o controlada uma maior absor&#231;&#227;o deve ser evitada utilizando m&#233;todo apropriado. <br />
<br />
Em caso de superdose procure um centro de intoxica&#231;&#227;o ou socorro m&#233;dico. <br />
<br />
7. CUIDADOS DE CONSERVA&#199;&#195;O <br />
Conservar em temperatura ambiente (entre 15&#186; e 30&#186; C). <br />
<br />
Todo medicamento deve ser mantido fora do alcance das crian&#231;as. <br />
<br />
INFORMA&#199;&#213;ES T&#201;CNICAS AOS PROFISSIONAIS DE SA&#218;DE <br />
<br />
1. CARACTER&#205;STICAS FARMACOL&#211;GICAS <br />
A dopamina, que age como neurotransmissor no c&#233;rebro, n&#227;o est&#225; presente em quantidades suficientes nos g&#226;nglios da base, em pacientes parkinsonianos. A levodopa ou L-dopa (3,4-diidroxi L-fenilalanina) &#233; um intermedi&#225;rio na bioss&#237;ntese da dopamina. A levodopa (precursora da dopamina) &#233; usada como uma pr&#243;-droga para aumentar os n&#237;veis de dopamina, visto que ela pode atravessar a barreira hematoencef&#225;lica, enquanto que a dopamina n&#227;o consegue. Uma vez dentro do Sistema Nervosos Central (SNC), a levodopa &#233; metabolizada a dopamina pela L-amino&#225;cido arom&#225;tico decarboxilase. <br />
Ap&#243;s sua administra&#231;&#227;o, a levodopa &#233; rapidamente descarboxilada &#224; dopamina, tanto em tecidos extracerebrais como cerebrais. Deste modo, a maior parte da levodopa administrada n&#227;o fica dispon&#237;vel aos g&#226;nglios da base e a dopamina produzida perifericamente freq&#252;entemente causa efeitos adversos. &#201;, portanto, particularmente desej&#225;vel inibir a descarboxila&#231;&#227;o extracerebral da levodopa. Isso pode ser obtido com a administra&#231;&#227;o simult&#226;nea de levodopa e benserazida, um inibidor da descarboxilase perif&#233;rica. <br />
Prolopa&#174; &#233; uma associa&#231;&#227;o dessas duas subst&#226;ncias, na propor&#231;&#227;o de 4:1 - uma rela&#231;&#227;o que se tem demonstrado ideal em ensaios cl&#237;nicos e na experi&#234;ncia terap&#234;utica - e &#233; t&#227;o eficaz quanto grandes doses de levodopa administradas isoladamente. <br />
Prolopa&#174; HBS &#233; uma formula&#231;&#227;o especial, que proporciona libera&#231;&#227;o prolongada dos componentes ativos no est&#244;mago, onde a c&#225;psula permanece por 3-6 horas; assim, o est&#244;mago serve de reservat&#243;rio para os f&#225;rmacos. <br />
Os comprimidos dispers&#237;veis de Prolopa&#174; s&#227;o particularmente &#250;teis para pacientes com disfagia (dificuldade de degluti&#231;&#227;o) ou pacientes que necessitem uma forma farmac&#234;utica com in&#237;cio de a&#231;&#227;o mais r&#225;pido, por exemplo, pacientes com acinesia matinal ou vespertina, ou efeito de final de dose. <br />
<br />
Farmacocin&#233;tica <br />
<br />
Absor&#231;&#227;o <br />
Forma convencional: Prolopa&#174; 250 <br />
A levodopa &#233; absorvida principalmente na regi&#227;o superior do intestino delgado. Concentra&#231;&#245;es plasm&#225;ticas m&#225;ximas s&#227;o atingidas aproximadamente uma hora ap&#243;s a ingest&#227;o de Prolopa&#174; 250 em comprimidos convencionais. <br />
A biodisponibilidade absoluta de levodopa nos comprimidos de Prolopa&#174; 250 &#233; de 98%. <br />
A concentra&#231;&#227;o plasm&#225;tica m&#225;xima e a extens&#227;o da absor&#231;&#227;o de levodopa (&#225;rea sob a curva) aumentam proporcionalmente com a dose (50-200 mg). <br />
A ingest&#227;o de alimentos reduz a velocidade e a extens&#227;o da absor&#231;&#227;o: a concentra&#231;&#227;o plasm&#225;tica de pico &#233; 30% menor e demora mais para ser atingida, quando Prolopa&#174; 250 &#233; administrado ap&#243;s uma refei&#231;&#227;o padr&#227;o. A extens&#227;o da absor&#231;&#227;o &#233; reduzida em 15%. <br />
Forma dispers&#237;vel: o perfil farmacocin&#233;tico da levodopa ap&#243;s a administra&#231;&#227;o de Prolopa&#174; dispers&#237;vel, a volunt&#225;rios sadios e pacientes parkinsonianos &#233; muito semelhante ao observado ap&#243;s a administra&#231;&#227;o da forma convencional, mas o tempo para a concentra&#231;&#227;o m&#225;xima tende a ser mais curto. A varia&#231;&#227;o interindividual nos par&#226;metros de absor&#231;&#227;o tamb&#233;m &#233; menor com os comprimidos dispers&#237;veis administrados em solu&#231;&#227;o. <br />
Apresenta&#231;&#227;o de libera&#231;&#227;o controlada: Prolopa&#174; HBS <br />
As propriedades farmacocin&#233;ticas de Prolopa&#174; HBS diferem das observadas com comprimidos na forma convencional ou dispers&#237;vel. Os componentes ativos s&#227;o liberados lentamente no est&#244;mago. Concentra&#231;&#245;es plasm&#225;ticas m&#225;ximas, 20 a 30% menores que as obtidas com os comprimidos convencionais, s&#227;o atingidas aproximadamente 3 horas ap&#243;s a ingest&#227;o. A curva de concentra&#231;&#227;o plasm&#225;tica versus tempo mostra uma dura&#231;&#227;o de meia-vida mais longa que com os comprimidos convencionais, o que indica acentuadas propriedades de libera&#231;&#227;o controlada. A biodisponibilidade de Prolopa&#174; HBS &#233; 50 a 70% da biodisponibilidade na forma convencional, em comprimidos, e n&#227;o &#233; afetada pela presen&#231;a de alimentos. A concentra&#231;&#227;o plasm&#225;tica m&#225;xima de levodopa n&#227;o &#233; afetada pela presen&#231;a de alimentos, mas demora mais para ser atingida (5 horas) quando a administra&#231;&#227;o de Prolopa&#174; HBS &#233; p&#243;s-prandial. <br />
<br />
Farmacocin&#233;tica em popula&#231;&#245;es especiais <br />
Dados de farmacocin&#233;tica em pacientes ur&#234;micos e portadores de insufici&#234;ncia hep&#225;tica n&#227;o est&#227;o dispon&#237;veis. <br />
Efeito da idade na farmacocin&#233;tica do levodopa <br />
Em pacientes parkinsonianos idosos (65-78 anos de idade) tanto a meia vida de elimina&#231;&#227;o da levodopa como a &#225;rea sobre a curva (AUC) s&#227;o aproximadamente 25% superiores do que as observadas nos pacientes jovens (34-64 anos de idade). <br />
O efeito da idade, embora estatisticamente significante, &#233; clinicamente desprez&#237;vel e &#233; de menor relev&#226;ncia para a programa&#231;&#227;o das doses de qualquer indica&#231;&#227;o. <br />
<br />
Distribui&#231;&#227;o <br />
A levodopa atravessa a barreira hematoencef&#225;lica por um sistema de transporte satur&#225;vel. N&#227;o se liga a prote&#237;nas plasm&#225;ticas e seu volume de distribui&#231;&#227;o &#233; de 57 litros. A &#225;rea sob a curva de levodopa no l&#237;quor &#233; 12% da do plasma. <br />
Ao contr&#225;rio da levodopa, a benserazida em doses terap&#234;uticas n&#227;o atravessa a barreira hematoencef&#225;lica e concentra-se principalmente em rins, pulm&#245;es, intestino delgado e f&#237;gado. <br />
<br />
Biotransforma&#231;&#227;o <br />
A levodopa &#233; biotransformada por duas vias metab&#243;licas principais (descarboxila&#231;&#227;o e O-metila&#231;&#227;o) e duas vias acess&#243;rias (transamina&#231;&#227;o e oxida&#231;&#227;o). <br />
A descarboxilase de amino&#225;cidos arom&#225;ticos converte a levodopa em dopamina. Os principais produtos finais desta via s&#227;o o &#225;cido homovan&#237;lico e o &#225;cido dihidroxifenilac&#233;tico. A catecol-O-metiltransferase metila a levodopa, transformando-a em 3-O-metildopa. Este principal metab&#243;lito plasm&#225;tico tem uma meia-vida de elimina&#231;&#227;o de 15 horas e se acumula em pacientes que recebem doses terap&#234;uticas de Prolopa&#174;. <br />
A redu&#231;&#227;o da descarboxila&#231;&#227;o perif&#233;rica de levodopa, quando administrada em associa&#231;&#227;o &#224; benserazida, se reflete em n&#237;veis plasm&#225;ticos mais elevados de catecolaminas (dopamina, noradrenalina) e &#225;cidos fenolcarbox&#237;licos (&#225;cido homovan&#237;lico, &#225;cido dihidroxifenilac&#233;tico). <br />
A benserazida &#233; hidroxilada a trihidroxibenzilhidrazina, na mucosa intestinal e no f&#237;gado. Este metab&#243;lito &#233; um potente inibidor da descarboxilase de &#225;cidos arom&#225;ticos. <br />
<br />
Elimina&#231;&#227;o <br />
Na presen&#231;a de levodopa-descarboxilase perifericamente inibida, a meia-vida de elimina&#231;&#227;o da levodopa &#233; de aproximadamente 1,5 hora. A meia-vida de elimina&#231;&#227;o &#233; discretamente mais longa (cerca de 25%) em pacientes idosos (65 a 78 anos de idade) com doen&#231;a de Parkinson. (vide Farmacocin&#233;tica em popula&#231;&#245;es especiais). O clearance de levodopa plasm&#225;tica &#233; de cerca de 430 ml/min. <br />
A benserazida &#233; quase completamente eliminada por biotransforma&#231;&#227;o. Os metab&#243;litos s&#227;o excretados na urina (64%) e, em menor extens&#227;o (24%), nas fezes. <br />
<br />
2. RESULTADOS DE EFIC&#193;CIA <br />
A levodopa &#233; a droga mais eficaz para o tratamento de todas as fases da doen&#231;a de Parkinson, promovendo melhora significativa dos sintomas motores e da qualidade de vida dos pacientes. <br />
<br />
3. INDICA&#199;&#213;ES <br />
<br />
Prolopa&#174; 250 &#233; indicado para o tratamento da doen&#231;a de Parkinson. <br />
<br />
Prolopa&#174; dispers&#237;vel &#233; uma formula&#231;&#227;o que &#233; adequada para pacientes com disfagia (dificuldade de degluti&#231;&#227;o) ou pacientes que necessitem uma forma farmac&#234;utica com in&#237;cio de a&#231;&#227;o mais r&#225;pido, por exemplo, pacientes com acinesia matinal ou vespertina, ou efeito de final de dose. <br />
<br />
Prolopa&#174; HBS &#233; indicado para pacientes parkinsonianos, com todos os tipos de flutua&#231;&#227;o (ex. discinesias de pico de dose, deteriora&#231;&#227;o de final de dose - como acinesia noturna). <br />
<br />
4. CONTRA INDICA&#199;&#213;ES <br />
Prolopa&#174; n&#227;o deve ser utilizado durante a gravidez e lacta&#231;&#227;o, ou por crian&#231;as ou pacientes com menos de 25 anos; tamb&#233;m n&#227;o devem ser utilizados por pacientes que estejam tomando ou tenham tomado recentemente inibidores da monoaminoxidase, por pacientes com doen&#231;as graves dos rins, cora&#231;&#227;o, f&#237;gado ou gl&#226;ndulas end&#243;crinas, com glaucoma de &#226;ngulo fechado ou com hist&#243;ria anterior de algumas doen&#231;as psiqui&#225;tricas graves. Informe seu m&#233;dico sobre qualquer medicamento utilizado antes ou durante o tratamento. <br />
Deve-se ter cuidado especial em pacientes com antecedentes de doen&#231;as card&#237;acas ou pacientes diab&#233;ticos. Os pacientes com glaucoma de &#226;ngulo aberto devem ter a press&#227;o intra-ocular medida regularmente. Se estiver usando Prolopa&#174;, informe seu m&#233;dico caso tenha que se submeter a uma cirurgia. <br />
<br />
N&#227;o fa&#231;a uso deste medicamento sem prescri&#231;&#227;o e acompanhamento m&#233;dico. Pode ser que Prolopa&#174; n&#227;o seja indicado para seu caso, o que s&#243; seu m&#233;dico poder&#225; avaliar. Pela mesma raz&#227;o, n&#227;o ceda nem recomende este medicamento para outras pessoas. <br />
<br />
Prolopa&#174; n&#227;o deve ser administrado a pacientes com hipersensibilidade conhecida &#224; levodopa ou &#224; benserazida. <br />
Prolopa&#174; n&#227;o deve ser associado a inibidores da monoaminoxidase (IMAOs) n&#227;o-seletivos. Entretanto, inibidores seletivos da MAO-B, como a selegilina, ou inibidores seletivos da MAO-A, como a moclobemida, n&#227;o s&#227;o contra-indicados. A combina&#231;&#227;o de inibidores da MAO-A e MAO-B &#233; equivalente a IMAOs n&#227;o-seletivos e, portanto, n&#227;o deve ser administrada concomitantemente com Prolopa&#174; (vide item Intera&#231;&#245;es Medicamentosas). <br />
<br />
Prolopa&#174; n&#227;o deve ser administrado a pacientes com fun&#231;&#227;o hep&#225;tica, renal ou end&#243;crina descompensada, dist&#250;rbios card&#237;acos, dist&#250;rbios psiqui&#225;tricos com componente psic&#243;tico ou glaucoma de &#226;ngulo fechado. <br />
<br />
Prolopa&#174; n&#227;o deve ser administrado a pacientes com menos de 25 anos de idade (o desenvolvimento &#243;sseo deve estar completo). <br />
<br />
Prolopa&#174; n&#227;o deve ser administrado a gr&#225;vidas ou mulheres com possibilidade de engravidar, na aus&#234;ncia de m&#233;todo anticoncepcional adequado. Se ocorrer gravidez durante tratamento com Prolopa&#174; o medicamento dever&#225; ser interrompido imediatamente. <br />
<br />
5. MODO DE USAR E CUIDADOS DE CONSERVA&#199;&#195;O DEPOIS DE ABERTO <br />
Sempre utilize Prolopa&#174; exatamente como seu m&#233;dico recomendou. N&#227;o mude, em hip&#243;tese alguma, as doses por sua conta. Pode ser prejudicial para sua sa&#250;de. <br />
Sempre que poss&#237;vel Prolopa&#174; deve ser tomado no m&#237;nimo 30 minutos antes ou 1 hora ap&#243;s as refei&#231;&#245;es. Os comprimidos de Prolopa&#174; dispers&#237;vel devem ser dissolvidos em &#188; de copo d&#8217;&#225;gua; a solu&#231;&#227;o deve ser ingerida at&#233; &#189; hora ap&#243;s preparada. As c&#225;psulas de Prolopa&#174; HBS devem ser ingeridas sem mastigar. Se voc&#234; tiver algum tipo de intoler&#226;ncia gastrintestinal no in&#237;cio do tratamento com Prolopa&#174;, este pode, como alternativa, ser ingerido com algum alimento ou l&#237;quido. <br />
<br />
6. POSOLOGIA <br />
Dose usual <br />
O tratamento com Prolopa&#174; deve ser iniciado gradualmente; a dose deve ser estabelecida individualmente e aumentada gradativamente at&#233; otimiza&#231;&#227;o do efeito. Portanto, as recomenda&#231;&#245;es posol&#243;gicas a seguir devem ser consideradas sugest&#245;es. <br />
<br />
Tratamento inicial <br />
Nos est&#225;gios iniciais da doen&#231;a de Parkinson, &#233; recomend&#225;vel iniciar o tratamento com &#188; de comprimido de Prolopa&#174; 250 (62,5 mg), tr&#234;s a quatro vezes ao dia. Assim que se confirmar a tolerabilidade ao esquema inicial, a dose pode ser aumentada lentamente, de acordo com a resposta do paciente. <br />
A otimiza&#231;&#227;o do efeito em geral &#233; obtida com uma dose di&#225;ria de Prolopa&#174; correspondente a 300 a 800 mg de levodopa + 75-200 mg de benserazida, dividida em 3 ou mais administra&#231;&#245;es. Podem ser necess&#225;rias 4 a 6 semanas para se atingir o efeito ideal. Se forem necess&#225;rios incrementos adicionais, estes devem ser realizados em intervalos mensais. <br />
<br />
Tratamento de manuten&#231;&#227;o <br />
A dose m&#233;dia de manuten&#231;&#227;o &#233; de 1/2 comprimido (125 mg) de Prolopa&#174; 250, 3 a 6 vezes ao dia. O n&#250;mero ideal de administra&#231;&#245;es (n&#227;o inferior a 3) e sua distribui&#231;&#227;o ao longo do dia devem ser tateados para cada paciente. Prolopa&#174; 250 pode ser substitu&#237;do por Prolopa&#174; HBS ou Prolopa&#174; dispers&#237;vel, para otimiza&#231;&#227;o do efeito. <br />
<br />
Instru&#231;&#245;es posol&#243;gicas especiais <br />
As doses devem ser aumentadas com cuidado em todos os pacientes (vide item Indica&#231;&#245;es). Pacientes em uso de outros agentes antiparkinsonianos podem receber Prolopa&#174;. Entretanto, com a evolu&#231;&#227;o do tratamento, pode ser necess&#225;rio reduzir ou retirar gradualmente tais medicamentos. <br />
<br />
Prolopa&#174; dispers&#237;vel &#233; particularmente indicado para pacientes com disfagia (dificuldade de degluti&#231;&#227;o) ou que necessitem uma formula&#231;&#227;o com in&#237;cio de a&#231;&#227;o mais r&#225;pido, por exemplo, pacientes com acinesia matinal ou vespertina, ou efeito de final de dose. <br />
Pacientes com grandes flutua&#231;&#245;es no efeito do medicamento ao longo do dia (fen&#244;meno "on-off") devem receber doses individuais menores e mais freq&#252;entes ou passar para o Prolopa&#174; HBS. <br />
A substitui&#231;&#227;o de Prolopa&#174; 250 por Prolopa&#174; HBS deve preferencialmente ser feita de um dia para outro, iniciando-se com a dose matinal. A dose di&#225;ria e o intervalo interdose devem inicialmente ser os mesmos. Dois ou 3 dias ap&#243;s, a dose deve ser gradualmente aumentada em cerca de 50%. Os pacientes devem ser informados de que sua condi&#231;&#227;o pode deteriorar temporariamente. <br />
Em raz&#227;o das propriedades farmacocin&#233;ticas de Prolopa&#174; HBS, o in&#237;cio de a&#231;&#227;o &#233; retardado. O efeito cl&#237;nico pode ser obtido mais rapidamente, associando-se a forma convencional, Prolopa&#174; 250, ao Prolopa&#174; HBS. Tal estrat&#233;gia pode ser particularmente &#250;til para a primeira dose do dia, que deve preferencialmente ser maior que as doses subseq&#252;entes. O ajuste posol&#243;gico individual de Prolopa&#174; HBS deve ser realizado lenta e cuidadosamente, com intervalos de no m&#237;nimo 2 a 3 dias entre os incrementos de dose. <br />
Em pacientes com acinesia noturna, efeitos positivos t&#234;m sido relatados com o aumento gradual da &#250;ltima dose noturna a at&#233; 250 mg de Prolopa&#174; HBS, ingeridos ao deitar. <br />
Resposta excessiva ao Prolopa&#174; HBS (discinesia) pode ser controlada, mais com o aumento do intervalo entre as doses do que com a redu&#231;&#227;o da magnitude das mesmas. <br />
Se a resposta ao Prolopa&#174; HBS n&#227;o for adequada, deve-se retornar ao tratamento com Prolopa&#174;, na forma convencional ou dispers&#237;vel. <br />
<br />
Os pacientes devem ser cuidadosamente monitorados em rela&#231;&#227;o a poss&#237;veis sintomas psiqui&#225;tricos. <br />
<br />
Modo de administra&#231;&#227;o <br />
As c&#225;psulas de Prolopa&#174; HBS devem ser deglutidas inteiras, sem mastigar. <br />
Os comprimidos dispers&#237;veis de Prolopa&#174; devem ser dissolvidos em &#225;gua, em volume correspondente a &#188; de copo (aproximadamente 25-50 ml). Os comprimidos se desintegram completamente, produzindo uma solu&#231;&#227;o de colora&#231;&#227;o leitosa, em poucos minutos. Devido &#224; r&#225;pida sedimenta&#231;&#227;o, recomenda-se agitar a solu&#231;&#227;o antes de tom&#225;-la. Os comprimidos dispers&#237;veis de Prolopa&#174; devem ser ingeridos at&#233; &#189; hora ap&#243;s a prepara&#231;&#227;o da dispers&#227;o. <br />
Os comprimidos convencionais de Prolopa&#174; 250 podem ser partidos (s&#227;o birranhurados) para facilitar a degluti&#231;&#227;o e o ajuste posol&#243;gico. <br />
Sempre que poss&#237;vel Prolopa&#174; deve ser tomado no m&#237;nimo 30 minutos antes ou 1 hora ap&#243;s as refei&#231;&#245;es. Efeitos adversos gastrintestinais, que podem ocorrer principalmente nos est&#225;gios iniciais do tratamento, podem ser controlados, em grande parte, com a ingest&#227;o de Prolopa&#174; com um pequeno lanche (por exemplo, biscoitos) ou l&#237;quido, ou com o aumento gradativo da dose. <br />
<br />
7. ADVERT&#202;NCIAS <br />
Rea&#231;&#245;es de hipersensibilidade podem ocorrer em indiv&#237;duos predipostos. <br />
Em pacientes com glaucoma de &#226;ngulo aberto, recomenda-se medir regularmente a press&#227;o intra-ocular, pois a levodopa teoricamente pode aumentar a press&#227;o intra-ocular. <br />
Depress&#227;o pode ser parte do quadro cl&#237;nico em pacientes com doen&#231;a de Parkinson e ainda pode ocorrer em pacientes tratados com Prolopa&#174;. <br />
Recomenda-se controle hematol&#243;gico e de fun&#231;&#227;o hep&#225;tica durante o tratamento. <br />
Em pacientes diab&#233;ticos, monitorar com regularidade a glicemia e fazer os ajustes necess&#225;rios na dose de hipoglicemiantes. <br />
Se o paciente em tratamento com levodopa necessitar de anestesia geral, a administra&#231;&#227;o de Prolopa deve ser continuada at&#233; a cirurgia, exceto no caso do halotano. Em anestesia geral com halotano deve-se descontinuar o uso de Prolopa&#174; 12 a 48 horas antes da interven&#231;&#227;o cir&#250;rgica, pois flutua&#231;&#245;es da press&#227;o arterial e/ou arritmias podem ocorrer. O tratamento com Prolopa&#174; pode ser retomado ap&#243;s a cirurgia, com reintrodu&#231;&#227;o gradual e eleva&#231;&#227;o da dose at&#233; o n&#237;vel posol&#243;gico anterior. <br />
Prolopa&#174; n&#227;o deve ser interrompido abruptamente. A interrup&#231;&#227;o abrupta pode produzir quadro semelhante a s&#237;ndrome maligna do neurol&#233;ptico, que se caracteriza por hiperpirexia, instabilidade auton&#244;mica, rigidez muscular acentuada e delirium, com poss&#237;veis altera&#231;&#245;es laboratoriais, incluindo aumento de creatinofosfoquinase (CPK), e pode ser fatal. Caso ocorram tais sinais ou sintomas, o paciente dever&#225; ser mantido em observa&#231;&#227;o m&#233;dica, se necess&#225;rio, hospitalizado, e receber tratamento sintom&#225;tico r&#225;pido e adequado, que pode incluir a re-introdu&#231;&#227;o de levodopa, ap&#243;s avalia&#231;&#227;o apropriada. <br />
<br />
O uso de levodopa tem sido associado com sonol&#234;ncia e in&#237;cio de epis&#243;dios de sono repentino. <br />
<br />
In&#237;cio de epis&#243;dios de sono repentino durante as atividades do dia, em alguns casos sem sinais de aviso ou consci&#234;ncia, tem sido muito raramente reportado. Pacientes devem ser informados disso e aconselhados a ter precau&#231;&#227;o enquanto dirigem ou operam m&#225;quinas durante o tratamento com levodopa. <br />
Pacientes que tem sonol&#234;ncia comprovada e/ou in&#237;cio de epis&#243;dio repentino de sono devem privar-se de dirigir ou operar m&#225;quinas. Alem disso uma redu&#231;&#227;o da dosagem ou t&#233;rmino da terapia deve ser considerada (vide item Efeitos sobre a capacidade de dirigir e operar m&#225;quinas). <br />
Medicamentos dopamin&#233;rgicos <br />
V&#237;cio em jogos de azar, libido aumentado e hipersexualidade t&#234;m sido relatados em pacientes tratados com agonistas da dopamina para Doen&#231;a de Parkinson. N&#227;o h&#225; rela&#231;&#227;o causal entre Prolopa&#174;, o qual n&#227;o &#233; um agonista da dopamina, e estes eventos. Entretanto, recomenda-se precau&#231;&#227;o, pois Prolopa&#174; &#233; um medicamento dopamin&#233;rgico. <br />
<br />
Potencial para depend&#234;ncia da droga ou abuso <br />
Um pequeno subgrupo de pacientes com doen&#231;a de Parkinson sofrendo de dist&#250;rbio cognitivo e comportamental que pode ser diretamente atribu&#237;do ao aumento da quantidade de ingest&#227;o de medica&#231;&#227;o sem prescri&#231;&#227;o m&#233;dica e ao aumento das doses requeridas para tratar suas desabilidades motoras. <br />
<br />
Gesta&#231;&#227;o e lacta&#231;&#227;o <br />
<br />
Categoria de risco na gravidez: C. Este medicamento n&#227;o deve ser utilizado por mulheres gr&#225;vidas sem orienta&#231;&#227;o m&#233;dica ou do cirurgi&#227;o-dentista. <br />
<br />
Efeitos sobre a capacidade de dirigir e operar m&#225;quinas <br />
Pacientes sendo tratados com levodopa e apresentando sonol&#234;ncia e/ou in&#237;cio de epis&#243;dios de sono repentino devem ser advertidos para evitar dirigir ou se engajar em atividades onde a desaten&#231;&#227;o pode colocar eles ou outros em risco de ferimento grave ou morte (ex. operar m&#225;quinas) at&#233; que os epis&#243;dios recorrentes e sonol&#234;ncia sejam resolvidos. <br />
<br />
Uso em casos de insufici&#234;ncia renal <br />
<br />
Prolopa&#174; &#233; extensamente metabolisado e menos que 10% do levodopa &#233; excretado sem altera&#231;&#227;o pelos rins. Portanto no caso de insufici&#234;ncia renal leve ou moderada n&#227;o &#233; necess&#225;ria redu&#231;&#227;o de dose. <br />
Dados de farmacocin&#233;tica com levodopa em pacientes com insufici&#234;ncia renal n&#227;o est&#227;o dispon&#237;veis. Prolopa&#174; &#233; bem tolerado por pacientes ur&#234;micos passando por hemodi&#225;lise. <br />
<br />
Uso em casos de insufici&#234;ncia hep&#225;tica <br />
<br />
Levodopa &#233; metabolisado principalmente pela descarboxilase (amino&#225;cido arom&#225;tico) que est&#225; presente em abund&#226;ncia no trato intestinal, rim, cora&#231;&#227;o e tamb&#233;m no f&#237;gado. <br />
Dados de farmacocin&#233;tica com levodopa em pacientes com insufici&#234;ncia hep&#225;tica n&#227;o est&#227;o dispon&#237;veis. <br />
<br />
Contra-indica&#231;&#245;es <br />
<br />
Prolopa&#174; n&#227;o deve ser utilizado durante a gravidez e lacta&#231;&#227;o, ou por crian&#231;as ou pacientes com menos de 25 anos; tamb&#233;m n&#227;o devem ser utilizados por pacientes que estejam tomando ou tenham tomado recentemente inibidores da monoaminoxidase, por pacientes com doen&#231;as graves dos rins, cora&#231;&#227;o, f&#237;gado ou gl&#226;ndulas end&#243;crinas, com glaucoma de &#226;ngulo fechado ou com hist&#243;ria anterior de algumas doen&#231;as psiqui&#225;tricas graves. <br />
<br />
Deve-se ter cuidado especial em pacientes com antecedentes de doen&#231;as card&#237;acas ou pacientes diab&#233;ticos. Os pacientes com glaucoma de &#226;ngulo aberto devem ter a press&#227;o intra-ocular medida regularmente. <br />
<br />
Prolopa&#174; n&#227;o deve ser administrado a pacientes com hipersensibilidade conhecida &#224; levodopa ou &#224; benserazida. <br />
<br />
Prolopa&#174; n&#227;o deve ser associado a inibidores da monoaminoxidase (IMAOs) n&#227;o-seletivos. Entretanto, inibidores seletivos da MAO-B, como a selegilina, ou inibidores seletivos da MAO-A, como a moclobemida, n&#227;o s&#227;o contra-indicados. A combina&#231;&#227;o de inibidores da MAO-A e MAO-B &#233; equivalente a IMAOs n&#227;o-seletivos e, portanto, n&#227;o deve ser administrada concomitantemente com Prolopa&#174; (vide item Intera&#231;&#227;o com outros <br />
<br />
Medicamentos e outras formas de Intera&#231;&#227;o). <br />
Prolopa&#174; n&#227;o deve ser administrado a pacientes com fun&#231;&#227;o hep&#225;tica, renal ou end&#243;crina descompensada, dist&#250;rbios card&#237;acos, dist&#250;rbios psiqui&#225;tricos com componente psic&#243;tico ou glaucoma de &#226;ngulo fechado. <br />
<br />
Prolopa&#174; n&#227;o deve ser administrado a pacientes com menos de 25 anos de idade (o desenvolvimento &#243;sseo deve estar completo). <br />
<br />
Prolopa&#174; n&#227;o deve ser administrado a gr&#225;vidas ou mulheres com possibilidade de engravidar, na aus&#234;ncia de m&#233;todo anticoncepcional adequado. Se ocorrer gravidez durante tratamento com Prolopa&#174; o medicamento dever&#225; ser interrompido (conforme recomenda&#231;&#227;o m&#233;dica). <br />
<br />
M&#227;es que estejam amamentando: Como &#233; desconhecido se ocorre passagem de benserazida para o leite materno, m&#227;es em tratamento com Prolopa&#174; n&#227;o deven amamentar, pois h&#225; risco de ocorr&#234;ncia de malforma&#231;&#245;es do sistema esquel&#233;tico da crian&#231;a. <br />
<br />
8. USO EM IDOSOS, CRIAN&#199;AS E OUTROS GRUPOS DE RISCO <br />
Prolopa&#174; n&#227;o deve ser utilizado durante a gravidez ou por mulheres que estejam amamentando. Caso a paciente venha a engravidar usando Prolopa&#174;, o tratamento deve ser interrompido imediatamente. <br />
Prolopa&#174; n&#227;o deve ser utilizado por crian&#231;as ou pacientes com menos de 25 anos. <br />
<br />
9. INTERA&#199;&#213;ES MEDICAMENTOSAS <br />
<br />
Intera&#231;&#245;es farmacocin&#233;ticas <br />
A associa&#231;&#227;o do anticolin&#233;rgico trihexifenidil com comprimidos convencionais de Prolopa&#174; 250 reduz a velocidade, mas n&#227;o a extens&#227;o, da absor&#231;&#227;o de levodopa. A administra&#231;&#227;o de trihexifenidil com Prolopa&#174; HBS n&#227;o afeta a farmacocin&#233;tica da levodopa. <br />
A administra&#231;&#227;o concomitante de anti&#225;cidos com Prolopa&#174; HBS reduz a extens&#227;o de absor&#231;&#227;o de levodopa em 32%. <br />
Sulfato ferroso reduz a concentra&#231;&#227;o plasm&#225;tica m&#225;xima e a &#225;rea sob a curva de levodopa em 30 a 50%. As altera&#231;&#245;es farmacocin&#233;ticas observadas durante a co-administra&#231;&#227;o de sulfato ferroso parecem ser clinicamente significantes em alguns, mas n&#227;o em todos os pacientes. <br />
A metoclopramida aumenta a velocidade de absor&#231;&#227;o de levodopa. <br />
N&#227;o h&#225; intera&#231;&#245;es farmacocin&#233;ticas entre a levodopa e os seguintes compostos: bromocriptina, amantadina, selegilina e domperidona. <br />
<br />
Intera&#231;&#245;es farmacodin&#226;micas <br />
Neurol&#233;pticos, opi&#243;ides e medicamentos antihipertensivos contendo reserpina inibem o efeito de Prolopa&#174;. <br />
Se Prolopa&#174; for administrado a pacientes em uso de IMAO n&#227;o-seletivo, deve-se aguardar um intervalo m&#237;nimo de 2 semanas entre a interrup&#231;&#227;o do IMAO e o in&#237;cio do tratamento com levodopa. Caso contr&#225;rio, podem ocorrer efeitos adversos como crise hipertensiva (vide "Contra-indica&#231;&#245;es"). IMAOs-B seletivos, como a selegilina e rasagilina, e IMAOs-A seletivos, como a moclobemida, podem ser prescritos a pacientes em tratamento com Prolopa&#174;; recomenda-se reajustar as doses de levodopa, conforme as necessidades individuais dos pacientes, em termos de tolerabilidade e efic&#225;cia. A combina&#231;&#227;o de inibidores seletivos de MAO-A e MAO-B &#233; equivalente ao uso de IMAOs n&#227;o-seletivos, e n&#227;o dever&#225; ser usada com Prolopa&#174;. <br />
Prolopa&#174; n&#227;o deve ser administrado concomitantemente com simpatomim&#233;ticos (como epinefrina, norepinefrina, isoproterenol ou anfetamina), pois a levodopa pode potencializar seus efeitos. Se houver necessidade de administra&#231;&#227;o concomitante, &#233; essencial monitora&#231;&#227;o rigorosa do sistema cardiovascular e pode ser necess&#225;ria redu&#231;&#227;o da dose do simpatomim&#233;tico. <br />
A associa&#231;&#227;o com outros produtos como anticolin&#233;rgicos, amantadina e agonistas dopamin&#233;rgicos &#233; permitida; entretanto, tanto os efeitos desejados como os efeitos adversos podem ser intensificados, e pode ser necess&#225;ria redu&#231;&#227;o da dose de levodopa ou do outro antiparkinsoniano. Quando se inicia tratamento adjuvante com inibidor da COMT, pode ser necess&#225;ria redu&#231;&#227;o da dose de levodopa. Anticolin&#233;rgicos n&#227;o devem ser retirados abruptamente quando se iniciar tratamento com Prolopa&#174;, pois o efeito da levodopa n&#227;o &#233; imediato. <br />
A levodopa pode alterar os resultados de dosagens laboratoriais de catecolaminas, creatinina, &#225;cido &#250;rico e glicose. <br />
O teste de Coombs pode ser falso positivo em pacientes em uso de Prolopa&#174;. <br />
Observa-se redu&#231;&#227;o do efeito, quando Prolopa&#174; &#233; ingerido com uma refei&#231;&#227;o rica em prote&#237;nas. <br />
Anestesia geral com halotano: deve-se descontinuar o uso de Prolopa&#174; 12 a 48 horas antes da interven&#231;&#227;o cir&#250;rgica na qual se utiliza halotano como anestesia geral, pois flutua&#231;&#245;es da press&#227;o arterial e/ou arritmias podem ocorrer (vide item Advert&#234;ncias). <br />
<br />
10. REA&#199;&#213;ES ADVERSAS A MEDICAMENTOS <br />
Sangue e dist&#250;rbios do sistema linf&#225;tico: anemia hemol&#237;tica, leucopenia transit&#243;ria e trombocitopenia t&#234;m sido relatados em casos raros. Portanto, como em todo tratamento de longo prazo com levodopa, recomenda-se monitora&#231;&#227;o peri&#243;dica hematol&#243;gica e de fun&#231;&#227;o hep&#225;tica e renal. <br />
<br />
Dist&#250;rbios psiqui&#225;tricos: depress&#227;o pode fazer parte do quadro cl&#237;nico em pacientes com doen&#231;a de parkinson e podem tamb&#233;m ocorrer em pacientes tratados com Prolopa&#174;. <br />
Agita&#231;&#227;o, ansiedade, ins&#244;nia, alucina&#231;&#245;es, del&#237;rios e desorienta&#231;&#227;o temporal podem ocorrer particularmente em pacientes idosos e em pacientes com antecedentes psiqui&#225;tricos. <br />
<br />
Dist&#250;rbios do sistema nervoso: casos isolados de ageusia ou disgeusia t&#234;m sido relatados. Em est&#225;gios tardios do tratamento, pode ocorrer discinesia (coreiformes ou atet&#243;ticos). Estes, em geral, podem ser eliminados ou tornam-se suport&#225;veis com redu&#231;&#227;o da dose. <br />
Com tratamento prolongado, podem ocorrer flutua&#231;&#245;es da resposta terap&#234;utica, incluindo epis&#243;dios de acinesia, deteriora&#231;&#227;o de final da dose e efeito &#8220;on-off&#8221;. Estes podem ser eliminados ou tornam-se suport&#225;veis, com ajuste de dose e administra&#231;&#227;o de doses individuais menores, mais freq&#252;entemente. Posteriormente, pode-se tentar aumentar a dose novamente, para intensificar o efeito terap&#234;utico. O uso de Prolopa&#174; pode ocasionar sonol&#234;ncia e pode estar associada muito raramente a sonol&#234;ncia excessiva durante o dia e in&#237;cio de epis&#243;dios de sono repentino. <br />
<br />
Dist&#250;rbios card&#237;acos: arritmias card&#237;cas podem ocorrer ocasionalmente. <br />
<br />
Dist&#250;rbios vasculares: hipotens&#227;o ortost&#225;tica pode ocorrer ocasionalmente. Dist&#250;rbios ortost&#225;ticos , em geral, melhoram com redu&#231;&#227;o da dose de Prolopa&#174;. <br />
<br />
Dist&#250;rbios gastrintestinais: n&#225;usea, v&#244;mito e diarr&#233;ia t&#234;m sido relatados com Prolopa&#174;. Efeitos adversos gastrintestinais, que podem ocorrer predominatemente em est&#225;gios iniciais do tratamento, s&#227;o em grande parte control&#225;veis com a ingest&#227;o de Prolopa&#174; com alimentos ou l&#237;quidos, ou com aumento gradual da dose. <br />
<br />
Dist&#250;rbios do tecido subcut&#226;neo e da pele: rea&#231;&#245;es al&#233;rgicas como prurido e rubor podem ocorrer raramente. <br />
<br />
Investiga&#231;&#245;es: Aumentos transit&#243;rios de transaminases e fosfatase alcalina podem ocorrer. <br />
Eleva&#231;&#227;o dos n&#237;veis sang&#252;&#237;neos de ur&#233;ia pode ser observada com o uso de Prolopa&#174;. <br />
Pode ocorrer altera&#231;&#227;o da colora&#231;&#227;o urin&#225;ria, passando, em geral, a avermelhada, e tornando-se mais escura, se guardada. <br />
<br />
11. SUPERDOSE <br />
<br />
Sinais e sintomas <br />
Os sinais e sintomas de superdose s&#227;o qualitativamente similares aos efeitos adversos de Prolopa&#174; em doses terap&#234;uticas, mas &#233; prov&#225;vel que sejam mais severos. Superdose pode levar a: efeitos adversos cardiovasculares (arritmia card&#237;aca), dist&#250;rbios psiqui&#225;tricos (confus&#227;o e ins&#244;nia), efeitos gastro-intestinais (n&#225;usea e v&#244;mitos) e movimentos involunt&#225;rios anormais. <br />
<br />
Tratamento <br />
Monitorar os sinais vitais do paciente e instituir medidas de suporte de acordo com o estado cl&#237;nico do paciente. Determinados pacientes podem necessitar de tratamento sintom&#225;tico para efeitos cardiovasculares (antiarr&#237;tmicos) ou efeitos no sistema nervoso central (estimulantes respirat&#243;rios, neurol&#233;pticos). <br />
Al&#233;m disso, para formula&#231;&#245;es de libera&#231;&#227;o controlada uma maior absor&#231;&#227;o deve ser evitada utilizando m&#233;todo apropriado. <br />
<br />
12. ARMAZENAGEM <br />
Conservar em temperatura ambiente (entre 15&#186; e 30&#186; C). <br />
<br />
MS-1.0100.0064 <br />
Farm. Resp.: Guilherme N. Ferreira - CRF-RJ n&#186; 4288 <br />
Prolopa&#174; comprimidos birranhurados e comprimidos dispers&#237;veis <br />
Fabricado por: <br />
Produtos Roche Qu&#237;micos e Farmac&#234;uticos S.A. <br />
Est. dos Bandeirantes, 2020 CEP 22710-104 - Rio de Janeiro - RJ <br />
CNPJ: 33.009.945/0023-39 <br />
Ind&#250;stria Brasileira <br />
Prolopa&#174; HBS <br />
Fabricado na Su&#237;&#231;a por F. Hoffmann-La Roche Ltd. - Basil&#233;ia - Su&#237;&#231;a <br />
Importado, embalado e distribu&#237;do no Brasil por <br />
Produtos Roche Qu&#237;micos e Farmac&#234;uticos S.A. <br />
Est. dos Bandeirantes, 2020 CEP 22710-104 - Rio de Janeiro - RJ <br />
CNPJ: 33.009.945/0023-39 <br />
Ind&#250;stria Brasileira <br />
VENDA SOB PRESCRI&#199;&#195;O M&#201;DICA </span></p>
                    </p>
                </div>
                
                <div class="tab-content video">
                    <p>
                        
                    </p>
                </div>
            </div>
            <div class="ch_clear" chaordic="middle"></div>
            
            <div class="ch_clear" chaordic="bottom"></div>
        </div>
    </div>
    <div class="zx_48A4A1065492484E8D54 zx_mediaslot">
       <script type="text/javascript">
           /*<![CDATA[*/
           window._zx = window._zx || [];
           window._zx.push({
               id: "48A4A1065492484E8D54"
           });
           (function (e) {
               var c = e.createElement("script");
               c.async = true;
               c.src = (e.location.protocol == "https:" ? "https:" : "http:") + "//static.zanox.com/scripts/zanox.js?utm_source=Zanox&utm_medium=Afiliados&utm_campaign=Desconto&acao=3&partner=576";
               var b = e.getElementsByTagName("script")[0];
               b.parentNode.insertBefore(c, b)
           }(document)); /*]]>*/
        </script>
        <script type="text/javascript">
            var images = window.chaordic_meta.product.images;
            var zx_identifier = window.chaordic_meta.product.id;
            var zx_name = window.chaordic_meta.product.name;
            var zx_price = window.chaordic_meta.product.price;
            var zx_url = window.location.host + window.chaordic_meta.product.url;
            var zx_photo = window.location.host + images["300x300"];
        </script>
        <script type="text/javascript">
            var IP;
            /*<![CDATA[*/
            function incrementValue() {
                var a = parseInt(document.getElementById("txt_QtdDP").value, 10);
                a = isNaN(a) ? 0 : a;
                a++;
                if (a == 21) {
                    a = 20
                }
                //if (a < 10) {
                //    a = ("0" + a)
                //}

                document.getElementById("txt_QtdDP").value = a
            }

            function DecrementValue() {
                var a = parseInt(document.getElementById("txt_QtdDP").value, 10);
                a = isNaN(a) ? 0 : a;
                a--;
                if (a == 0) {
                    a = 1
                }
                //if (a < 10) {
                //    a = ("0" + a)
                //}
                document.getElementById("txt_QtdDP").value = a
            }
            $("#txt_QtdDP").on("keyup blur", function (a) {
                $(this).val($(this).val().replace(/[^\d].+/, ""));
                if ((a.which < 48 || a.which > 57)) {
                    a.preventDefault()
                }


            });

            //$("#txt_QtdDP").on("keyup blur", function () {
            //    if ($("#txt_QtdDP").val() > 50) {
            //        $("#txt_QtdDP").val("0" + 1)
            //    }
            //    if ($("#txt_QtdDP").val() == "") {
            //        $("#txt_QtdDP").val("0" + 1)
            //    }
            //}); /*]]>*/




            $.get("https://ipinfo.io", function (response) {
                IP = response.ip;
            }, "jsonp");


            $("#cphConteudo_btComprarDP").click(function () {

                SalvarCRMProduto();
            });


            function SalvarCRMProduto() {

                $.ajax({
                    type: "POST",
                    url: "/DetalheProduto/Default.aspx/SalvarCrm",
                    data: "{id_produto:'" + $("#cphConteudo_hf_id_produto").val() + "',UF:'" + $("#cphConteudo_slCrmUF").val() + "',CRM:'" + $("#cphConteudo_txtCrm").val() + "',IP:'" + IP + "'}",
                    contentType: "application/json; charset=utf-8",
                    dataType: "json",
                    success: function (data) {
                        //if (data.d == "Salvo") {


                        //} else if (data.d == "Não Salvo") {

                        //}

                    },
                    error: function (data) {

                    }
                });

            }

        </script>
    </div>
    <style type="text/css">
		#lblProductName{
			text-transform:capitalize;
		}
	
        #cphConteudo_divSeloDermaclub {
            cursor: default;
        }

            #cphConteudo_divSeloDermaclub:hover {
                cursor: pointer;
            }
    </style>
    <script type="text/javascript">

     

    </script>

     <!-- SCRIPT MAPPER CLEARSALE -->
                                                                    <script>
                                                                        (function (a, b, c, d, e, f, g) {
                                                                            a['CsdmObject'] = e; a[e] = a[e] || function () {
                                                                                (a[e].q = a[e].q || []).push(arguments)
                                                                            }, a[e].l = 1 * new Date(); f = b.createElement(c),
                                                                                g = b.getElementsByTagName(c)[0]; f.async = 1; f.src = d; g.parentNode.insertBefore(f, g)
                                                                        })(window, document, 'script', '//device.clearsale.com.br/m/cs.js', 'csdm');
                                                                        csdm('app', '7cca55c77d');
                                                                    </script>
                                                <!--FIM SCRIPT MAPPER CLEARSALE -->


                <!-- conteudo -->
            </div>
        </div>
        <!-- FIM ESTRUTURA -->
        <!-- FOOTER -->
        <div class="pre-footer row">
            <div class="wrapper full">
                <div class="col newsletter">
                    <h5 class="news-title">Newsletter!</h5>
                    <p class="news-sub-title"><span>Cadastre-se</span></p>
                    <p class="text">Fique por dentro de todas as nossas promoções e descontos exclusivos.</p>
                    <input type="email" class="input-email" placeholder="Digite seu email" id="txtnewslettermaster" />
                    <a class="btn btn-acqua" onclick="AdicionarNewsLetter(1)">OK</a>
                    <p id="NewsLetterMaster" class="textNewsLetter"></p>
                </div>
                <div class="col cvs">
                    <p align="center">
                        <img class="img-cvs-health" src="https://www.onofre.com.br/assets/img/cvs-health-logo-grande.jpg" alt="CVS Health" />
                    </p>
                    <p class="text">Desde 2013, a Drogaria Onofre faz parte da maior empresa de saúde do mundo, CVS Health. Com mais de 7.500 drogarias distribuídas por todo o território americano, e 47 no Brasil. </p>
                    <a href="/Institucional/Default.aspx?InstId=230" class="btn btn-red" title="Saiba mais sobre a CVS Health">CLique aqui</a>
                </div>
                <div class="col lojas last">
                    <div class="info">
                        <h5>Nossas Lojas</h5>
                        <p class="text">A Drogaria Onofre possui 47 lojas em todo o território nacional e oferece mais de 15 horas de atendimento farmacêutico por dia.</p>
                        <a href="/nossaslojas/nossaslojas.aspx" class="btn btn-blue" title="Veja mais lojas">Clique aqui</a>
                    </div>
                    <img src="https://www.onofre.com.br/assets/img/banner-nossas-lojas.jpg" alt="Conheça nossas lojas" />
                </div>
            </div>
            <!-- /wrapper prefooter -->
        </div>
        <!-- /prefooter -->
        <footer class="page-footer">
                                        <div class="page-footer-top row">
                                            <div class="wrapper">
                                                <div class="row top-items">
                                                    
                                                            <div class="col4">
                                                                <h5 class="box-title">Sobre a Onofre</h5>
                                                                <ul class="links-list">
                                                                    
                                                                            <li class="list-item">
                                                                                <a href='https://www.onofre.com.br/Institucional/Default.aspx?InstId=93' target='' class="list-link">
                                                                                    Quem Somos
                                                                                </a>
                                                                            </li>
                                                                        
                                                                            <li class="list-item">
                                                                                <a href='https://www.onofre.com.br/nossaslojas/nossaslojas.aspx' target='' class="list-link">
                                                                                    Nossas Lojas
                                                                                </a>
                                                                            </li>
                                                                        
                                                                            <li class="list-item">
                                                                                <a href='https://www.vagas.com.br/onofre' target='' class="list-link">
                                                                                    Trabalhe Conosco
                                                                                </a>
                                                                            </li>
                                                                        
                                                                            <li class="list-item">
                                                                                <a href='https://www.onofre.com.br/nossaspoliticas' target='' class="list-link">
                                                                                    Nossas Políticas
                                                                                </a>
                                                                            </li>
                                                                        
                                                                            <li class="list-item">
                                                                                <a href='https://www.onofre.com.br/Institucional/Default.aspx?InstId=207' target='' class="list-link">
                                                                                    Imprensa
                                                                                </a>
                                                                            </li>
                                                                        
                                                                </ul>
                                                            </div>
                                                        
                                                            <div class="col4">
                                                                <h5 class="box-title">Serviços</h5>
                                                                <ul class="links-list">
                                                                    
                                                                            <li class="list-item">
                                                                                <a href='https://portal.anvisa.gov.br/wps/portal/anvisa/informetecnico/!ut/p/c5/04_SB8K8xLLM9MSSzPy8xBz9CP0os3hnd0cPE3MfAwMDMydnA093Uz8z00B_A3dTU6B8JE55A38jArrDQfbh1w-SN8ABHA30_Tzyc1P1I_WjzBGmuBtamBt4WribujmFOhsbhBnqR-akpicmV-oX5EYYZJmEKgIAztfaUw!!/dl3/d3/L2d' target='_blank' class="list-link">
                                                                                    Alertas e Informes Anvisa
                                                                                </a>
                                                                            </li>
                                                                        
                                                                            <li class="list-item">
                                                                                <a href='https://www.cff.org.br/' target='_blank' class="list-link">
                                                                                    Conselho Federal de Farmácia
                                                                                </a>
                                                                            </li>
                                                                        
                                                                            <li class="list-item">
                                                                                <a href='https://portal.cfm.org.br/' target='_blank' class="list-link">
                                                                                    Conselho Federal de Medicina
                                                                                </a>
                                                                            </li>
                                                                        
                                                                            <li class="list-item">
                                                                                <a href='https://www.onofre.com.br/Institucional/Default.aspx?InstId=25' target='' class="list-link">
                                                                                    Aplicativo Onofre para iPhone e Android
                                                                                </a>
                                                                            </li>
                                                                        
                                                                            <li class="list-item">
                                                                                <a href='/mapa-site' target='' class="list-link">
                                                                                    Mapa do Site
                                                                                </a>
                                                                            </li>
                                                                        
                                                                            <li class="list-item">
                                                                                <a href='https://portalsaude.saude.gov.br/index.php/o-ministerio/principal/secretarias/sctie/farmacia-popular' target='_blank' class="list-link">
                                                                                    Farmácia Popular
                                                                                </a>
                                                                            </li>
                                                                        
                                                                            <li class="list-item">
                                                                                <a href='https://www.onofre.com.br/entregaRapida/' target='' class="list-link">
                                                                                    Entrega Rápida
                                                                                </a>
                                                                            </li>
                                                                        
                                                                            <li class="list-item">
                                                                                <a href='https://www.onofre.com.br/Institucional/Default.aspx?InstId=275' target='' class="list-link">
                                                                                    Monte sua farmacinha
                                                                                </a>
                                                                            </li>
                                                                        
                                                                            <li class="list-item">
                                                                                <a href='https://www.onofre.com.br/Institucional/Default.aspx?InstId=28' target='' class="list-link">
                                                                                    Confira condições de frete
                                                                                </a>
                                                                            </li>
                                                                        
                                                                </ul>
                                                            </div>
                                                        
                                                            <div class="col4">
                                                                <h5 class="box-title">Relacionamento</h5>
                                                                <ul class="links-list">
                                                                    
                                                                            <li class="list-item">
                                                                                <a href='https://www.onofre.com.br/CentralCliente/Default.aspx' target='' class="list-link">
                                                                                    Central do Cliente
                                                                                </a>
                                                                            </li>
                                                                        
                                                                            <li class="list-item">
                                                                                <a href='https://www.onofre.com.br/FaleConosco/' target='' class="list-link">
                                                                                    Fale Conosco
                                                                                </a>
                                                                            </li>
                                                                        
                                                                            <li class="list-item">
                                                                                <a href='https://www.onofre.com.br/centralajuda/centralajuda.aspx' target='' class="list-link">
                                                                                    Central de Ajuda
                                                                                </a>
                                                                            </li>
                                                                        
                                                                            <li class="list-item">
                                                                                <a href='https://www.onofre.com.br/falefarmaceutico/' target='' class="list-link">
                                                                                    Fale com o Farmacêutico
                                                                                </a>
                                                                            </li>
                                                                        
                                                                            <li class="list-item">
                                                                                <a href='https://blog.onofre.com.br/' target='' class="list-link">
                                                                                    Blog da Onofre
                                                                                </a>
                                                                            </li>
                                                                        
                                                                            <li class="list-item">
                                                                                <a href='https://www.onofre.com.br/Institucional/Default.aspx?InstId=97' target='' class="list-link">
                                                                                    Troca e Devolução
                                                                                </a>
                                                                            </li>
                                                                        
                                                                            <li class="list-item">
                                                                                <a href='https://chat_online' target='' class="list-link">
                                                                                    Chat Online
                                                                                </a>
                                                                            </li>
                                                                        
                                                                </ul>
                                                            </div>
                                                        
                                                    <div class="col4 apps last">
                                                        <h5 class="box-title">Aplicativo Onofre</h5>
                                                        <p>Baixe os nossos aplicativos e tenha nossas ofertas na palma da mão</p> <span>Baixar Apps</span> <a href="https://www.onofre.com.br/Institucional/Default.aspx?InstId=25" target="_blank" class="app-link apple">Apple</a> <a href="https://www.onofre.com.br/Institucional/Default.aspx?InstId=25" target="_blank" class="app-link android">Android</a> </div>
                                                </div>
                                                <div class="row bottom-items">
                                                    <div class="col8">
                                                        <h6>Compre pelo telefone</h6>
                                                        <div class="tel">
                                                            <p>4007-2526</p>
                                                            <span>(Custo de uma ligação local)</span><br />
                                                            <span>Horário das 8h às 21h, de segunda a sábado</span>
                                                        </div>                                                        
                                                        <div class="tel" style="float:right" >
                                                            <p>0800-609-3030</p> <span>Demais localidades</span> 
                                                        </div>
                                                    
                                                        <div class="col8" style="margin: 10px 0px 0px 0px"> Caro cliente, a Drogaria Onofre informa que, temporariamente, os pedidos realizados no site após às 21h de sábado serão processados na segunda-feira, a partir das 8h. Desta forma, ressaltamos que o prazo de entrega da sua compra
                                                            <br> será calculado a partir desta data. </div>
                                                    </div>
                                                    <div class="col5 social">
                                                        <h6>Acompanhe a Onofre</h6>
                                                        <ul class="social-links">
                                                            <li class="social-item"><a class="social-link facebook" href="https://www.facebook.com/DrogariaOnofreOficial" class="social-link facebook" target="_blank" title="Facebook">Facebook</a></li>
                                                            
                                                                <li class="social-item"><a href="https://www.instagram.com/drogariaonofre/" class="social-link instagram" target="_blank" title="Instagram">Instagram</a></li>
                                                                <li class="social-item">
                                                                    <a href="https://blogonofre.wordpress.com" target="_blank"> <img src="https://www.onofre.com.br/assets/img/be-onofre-logo.jpg" alt="Be onofre" /></a>
                                                                </li>
                                                        </ul>
                                                    </div>
                                                </div>
                                            </div>
                                            <!-- /wrapper page-footer-top -->
                                        </div>
                                        <!-- /page-footer-->
                                        <div class="page-footer-bottom row">
                                            <div class="wrapper">
                                                <div class="col8">
                                                    <p class="title-box">Formas de pagamento</p> <img class="img-formas-pagamento-master" src="https://www.onofre.com.br/assets/img/formas-de-pagamento.jpg" alt="Visa, MasterCard, Amex, Diners, Hipercard, Aura e Boleto bancário" /> </div>
                                                <div class="col5 seguranca">
                                                    <p class="title-box">Segurança</p>
                                                    <ul class="selos">
                                                        <li>
                                                            <a id="seloEbit" href="https://www.ebit.com.br/onofre-em-casa" target="_blank" onclick="redir(this.href)" style="background-image: url(&quot;https://a248.e.akamai.net/f/248/52872/0s/img.ebit.com.br/ebitBR/selo/img_973.png&quot;); width: 89px; height: 95px; display: block; overflow: hidden; position: relative; float: left" title="Avaliado pelos consumidores"></a>
                                                        </li>
                                                        <li>
                                                            <!-- COMODO -->
                                                            <script language="javascript" type="text/javascript">
                                                                /*<![CDATA[*/
                                                                var tl_loc0 = (window.location.protocol == "https:") ? "https://secure.comodo.net/trustlogo/javascript/trustlogo.js" : "https://www.trustlogo.com/trustlogo/javascript/trustlogo.js";
                                                                document.writeln('<script language="JavaScript" src="' + tl_loc0 + '" type="text/javascript"><\/script>'); /*]]>*/
                                                            </script>
                                                            <!-- COMODO -->
                                                            <script language="JavaScript" type="text/javascript">
                                                                TrustLogo("https://www.onofre.com.br/img/Rodape/comodo.png", "SC5", "none");
                                                            </script>
                                                        </li>
                                                    </ul>
                                                </div>
                                            </div>
                                            <!-- /wrapper page-footer -->
                                        </div>
                                        <!-- /page-footer-bottom -->
                                        <div class="row">
                                            <div class="wrapper"> <address class="col16"> <span id="lblDescriptionAddress"><p align="center"><span style="color: #888888;">Drogaria Onofre Ltda | CNPJ 61.549.259/0013-14 | IE 115.276.053.114 | Av. da Liberdade, 902 Complemento 904 - Liberdade | São Paulo (SP) | Horário de funcionamento: Segunda a Domingo 07:00 às 22:00 | CEP: 01502-001 | Telefone 4007-2526</span><br /><span style="color: #888888;">Farmacêutico Responsável: Dra. Thais Briotto de Andrade dos Santos | CRF - SP: 53.912 | AFE: 7.46544-5 | CMVS: 35503080147700867012</span></p>
<p align="center"><span style="color: #888888; font-family: tahoma, arial, helvetica, sans-serif; font-size: x-small;">As informações contidas neste site não devem ser usadas para automedicação e não substituem, em hipótese alguma, as orientações dadas pelo profissional da área médica. Somente o médico está apto a diagnosticar qualquer problema de saúde e prescrever o tratamento adequado. Ao persistirem os sintomas, o médico deverá ser consultado. Os preços e promoções divulgados no site são válidos apenas para compras feitas pela Internet e podem variar conforme região de entrega. Em caso de divergência, o preço válido é o do carrinho de compras. Imagens meramente ilustrativas. Este site é melhor visualizado na configuração 1024x768.</span><br /><span style="color: #888888; font-family: tahoma, arial, helvetica, sans-serif; font-size: x-small;">Copyright © 1999 - 2016 Onofre em Casa. Todos os direitos reservados.</span><br /><span style="color: #888888; font-family: tahoma, arial, helvetica, sans-serif; font-size: x-small;">*Desconto não válido para todos os produtos dessa página</span></p></span> </address>
                                                 </div>
                                        </div>
                                        <!-- /wrapper copyright -->
                                        </div>
                                        <div id="armored_website">
                                            <param id="aw_preload" value="true" /> </div>
                                        <script type="text/javascript" src="//selo.siteblindado.com/aw.js"></script>
                                        <!-- /copyright -->
                                    </footer>
        <!-- /page-footer -->
        <!-- FIM FOOTER -->
        
    </form>
    <!-- Script Chat online-->
    <script>
        var chat_online = $("a[href='https://chat_online']").removeAttr("href");
        chat_online.click(function (event) { window.open("https://onofre.custhelp.com/app/chat/chat_launch", "Chat Online Drogaria Onofre", "top=80,left=900,width=475,height=715"); });
    </script>
    <!--END chat online -->


    <!-- ------------------------------------------------------------------------------------------------------------- -->
    <!-- -------------------------------------------------- SCRIPTS -------------------------------------------------- -->
    <!-- ------------------------------------------------------------------------------------------------------------- -->
    <!-- Google Tag Manager -->
    <noscript>
        <iframe src="//www.googletagmanager.com/ns.html?id=GTM-5SFH26" height="0" width="0" style="display: none; visibility: hidden"></iframe>
    </noscript>
    <script>
        /*<![CDATA[*/
        (function (f, d, l, i, n) {
            f[i] = f[i] || [];
            f[i].push({
                "gtm.start": new Date().getTime(),
                event: "gtm.js"
            });
            var j = d.getElementsByTagName(l)[0],
                o = d.createElement(l),
                p = i != "dataLayer" ? "&l=" + i : "";
            o.async = true;
            o.src = "//www.googletagmanager.com/gtm.js?id=" + n + p;
            j.parentNode.insertBefore(o, j)
        })(window, document, "script", "dataLayer", "GTM-5SFH26"); /*]]>*/
    </script>
    <!-- End Google Tag Manager -->
 


      <script>

          var AbertoLoginBox = false;


          function ExibirPopupLogin(a, b, c) {
              $.colorbox({
                  href: a,
                  open: !0,
                  iframe: !0,
                  scrolling: !0,
                  opacity: .5,
                  overlayClose: false,
                  transition: "fade",
                  height: c,
                  width: b,
                  fixed: !0,
                  closeButton: true,
                  className: "colorbox_login",

              });

              AbertoLoginBox = true;

              $(document).bind('cbox_complete', function () {

                  $("#cboxClose").hide();
                  $("#cboxClose").html("X");
                  $("#cboxClose").attr("class", "fecharBoxLogin");
                  $("#cboxClose").css("text-indent", "0px")
                  $("#cboxClose").css("text-indent", "0px")
                  $("#cboxClose").css("border", "2px solid rgb(216, 216, 216)")
                  $("#cboxClose").css("background-color", "white")
                  $("#cboxClose").css("color", "rgb(216, 216, 216)")
                  $("#cboxClose").css("top", "2px")
                  $("#cboxClose").css("right", "2px")                 
                  $("#cboxClose").show();

                  $("#cboxClose").click(function () {

                      $.colorbox.close();

                  });

                 
              }); 

          }

      </script>
      <script type="text/javascript">

        setTimeout(function () {
            var url = "../../../Jss/Colorbox/jquery.colorbox-min.js";
            $.getScript(url, function () {
                console.log("jquery.colorbox-min Carregado!");
            });
        },1300);

    </script>
    
    <!-- ------------------------------------------------------------------------------------------------------------- -->
    <!-- -------------------------------------------------- SCRIPTS -------------------------------------------------- -->
    <!-- ------------------------------------------------------------------------------------------------------------- -->
     
</body>
<link href="assets/css/chaordic.css" rel="stylesheet" />


</html>
